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 There has been a dramatic increase in obesity, which presents a risk of many chronic 
health problems. Recent studies have shown that obese individuals harbor an abnormal gut 
microbiota (dysbiosis), which has sparked interest in the gut microbiota as a target for weight 
management. Dietary fiber and whole grains that can be metabolized by gut microbiota have been 
shown to promote the growth of beneficial bacteria in the gut. Increased consumption of dietary 
fiber and whole grains may improve host / gut microbiota interactions in obesity and other 
metabolic diseases by normalizing gut dysbiosis. The present thesis describes two research 
projects to assess the impact of dietary fibers and whole grain on gut microbiota. In the first study, 
six dietary fibers [pectin, guar gum, inulin, arabinoxylan, β-glucan, and resistant starch type 2 
(RS-2)] were subjected to in vitro digestion and fermentation using fecal samples from obese and 
normal weight individuals. Pyrosequencing was used to assess the impact of each dietary fiber on 
the gut microbiota community. Short/branched chain fatty acids (SCFA/BCFA) and carbohydrate 
utilization were correlated with proportions of bacterial taxa. The data showed that RS-2 caused 
the most dynamic change of the whole microbiota community and Bifidobacterium increased 
almost 10-fold on pectin substrate compared with the control. Certain taxa may be targeted to 
increase SCFA production or increase dietary fiber utilization. For instance, Ruminococcaceae 
and Faecalibacterium displayed positive correlations with butyrate production and while a strong 
positive relationship was shown between β-glucan utilization and Firmicutes. In the second study, 
since SCFA can influence hormones involved in energy absorption, utilization, and storage, the 
SCFA profile from five whole grains (wheat, rye, corn, rice, and oats) using an in vitro method 
  
was evaluated. There were large differences in fermentation profiles among individuals, even 
when supplied with the same dietary fiber. The obese type microbiota was less efficient at 
butyrate production and less metabolically active than the normal weight type microbiota initially, 
but given sufficient whole grain substrates the bacteria quickly became metabolically active.  
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INTRODUCTION 
 About one-third of U.S. adults (33.8%) are obese. Obesity is the key contributor to many 
metabolic syndromes worldwide such as hypertension, dyslipidemia, type 2 diabetes, colon 
cancer, cardiovascular disease and stroke [1]. 
 Human intestines harbor an immensely complex and diverse microbiota that can be 
viewed as a super metabolic organ (15-fold more genes than our host genome) with about 1014 
bacteria and Achaea, composed of approximately 1,100 prevalent species [2]. The gut microbota 
has been found to affect energy harvest from the diet and fat storage [3]. Germ-free mice are 
protected from diet induced obesity, and upon gut microbiota colonization a significant increase 
(42%) of body fat content occurs [4]. 
Gut microbiota composition has been associated with obesity and many metabolic 
diseases. Studies [5-7] show that there is a shift between two bacterial phyla (Bacteroidetes and 
Firmicutes in obese state): a reduction of Bacteroidetes and a proportional increase of Firmicutes 
in the process of weight gain. Also compared with lean people, there are relatively less 
Bacteroidetes in obese people, which are increased with weight loss [8, 9]. 
 The gut microbiota can be influenced by diet, particularly by dietary fibers and whole 
grain in the diet. Indeed, certain dietary fibers can favor the growth of one or a group of bacteria 
at the expense of others [10]. Moreover, obese people consistently consume less dietary fiber than 
normal-weight individuals [11]. 
Objectives and Hypotheses 
 We hypothesized that whole grain and dietary fibers may be an excellent way to treat the 
obesity by altering and modulating of the gut microbiota. Since whole grains and dietary fibers 
are actually composed of many chemical compounds with different physiological effects, we 
further hypothesized that different whole grains and dietary fibers would exhibit varying efficacy 
with respect to correcting the abnormal gut microbiota in obesity. Thus, the overall objective of 
this research was to discover the specific types of dietary fiber and whole grain that are most 
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efficient at altering the fecal microbiota composition or metabolism from obese individuals 
towards a composition and function more indicative of normal-weight individuals in an effort to 
identify candidate dietary fibers that will help prevent or treat obesity.   
Organization 
 This thesis is organized as follows: a literature review (Chapter 1) followed by 
manuscripts describing two research projects (Chapters 2 and 3).  Chapter 1 has been formatted 
using the guidelines for Critical Reviews in Food Science and Nutrition; Chapter 2 for Applied 
and Environmental Microbiology; and Chapter 3 for Anaerobe. Reference can be found at the end 
of each chapter.  
 
References 
[1] Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, et al. Impact of 
overweight on the risk of developing common chronic diseases during a 10-year period. Archives 
of Internal Medicine 2001;161:1581. 
[2] Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut 
microbial gene catalogue established by metagenomic sequencing. Nature 2010;464:59-65. 
[3] Backhed F. The gut microbiota as an environmental factor that regulates fat storage. 
Proceedings of the National Academy of Sciences 2004;101:15718-23. 
[4] Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as 
an environmental factor that regulates fat storage. Science's STKE 2004;101:15718. 
[5] Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes 
associated with obesity. Nature 2006;444:1022-3. 
[6] Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, Yu Y, et al. Human gut 
microbiota in obesity and after gastric bypass. Proceedings of the National Academy of Sciences 
2009;106:2365. 
3 
 
 
[7] Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-
associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027-131. 
[8] Ley RE, Turnbaugh PJ, Jeffrey SK. Microbial ecology Human gut microbes associated 
with obesity. Nature 2006;444:1022-3. 
[9] Schwiertz A, Taras D, Schäfer K, Beijer S, Bos NA, Donus C, et al. Microbiota and 
SCFA in Lean and Overweight Healthy Subjects. Obesity 2009;18:190-5. 
[10] Gibson GR, Probert HM, Van Loo J, Rastall RA, Roberfroid MB. Dietary modulation of 
the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 2004;17:259-75. 
[11] Davis JN, Hodges VA, Gillham MB. Normal-weight adults consume more fiber and fruit 
than their age-and height-matched overweight/obese counterparts. Journal of the American 
Dietetic Association 2006;106:833-40. 
 
 
  
4 
 
 
CHAPTER 1. INFLUENCE OF WHOLE GRAINS AND DIETARY FIBER ON THE 
GUT MICROBIOTA AND OBESITY 
1.1. Abstract 
There has been a dramatic increase in obesity, which presents a risk of many chronic 
health problems. Recent evidence suggests that obese people have a different gut microbiota 
composition compared to normal weight individuals and the gut microbiota is involved in nutrient 
absorption and energy balance. The proposed mechanisms that describe the influence of the gut 
microbiota on obesity include: 1) modulating energy harvest from the diet, 2) influencing energy 
and fat utilization, and 3) modulating low grade inflammation. A number of epidemiological 
studies have established that high dietary fiber / whole grain diets are associated with weight loss, 
suggesting that whole grains and dietary fibers may be important candidates to modulate the gut 
ecosystem to a healthier state and treat obesity. There are diverse types of dietary fiber and whole 
grain with varying structures that may have differing physiological impacts on the gut microbiota 
and obesity prevention.  
1.2. Introduction 
Globally, 300 million people are obese and more than 1 billion are overweight 
(Stephenson et al., 2010).  In the US, one third of adults (33.8%) are obese (Flegal et al., 2010). 
Obesity has been viewed as one of the major public health problems in both adults and children, 
leading to conditions such as heart disease, stroke, type 2 diabetes, and certain types of cancer 
(Musso et al., 2010). 
The underlying reasons contributing to obesity are complex. Although it essentially 
results from energy imbalance involving consuming more calories than expended, genetic 
background and environmental factors also play a role. Notably, epidemiological studies suggest 
that the recent increased prevalence in obesity cannot solely be explained by genetics, food 
availability, and behavioral changes (Raoult, 2008). The human microbiota has been recently 
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identified as a contributing factor to obesity, with different compositions observed between lean 
and obese individuals (Ley et al., 2005; Ley et al., 2006a; Ley et al., 2006b). The altered gut 
bacteria in obese individuals, or “dysbiosis”, may lead to increased energy absorption and storage 
(Mandard, 2005).  
Dietary fiber and whole grains that can be metabolized by the gut microbiota have been 
shown to promote the growth of beneficial bacteria in the gut (Liu, 2007; Quigley, 2011). 
Increased consumption of dietary fiber and whole grains may improve host / gut microbiota 
interactions in obesity and other metabolic diseases by normalizing the dysbiosis of the gut 
microbiota. Because the diverse compositions and structures of dietary fibers and whole grains 
lead to differing impacts on the gut microbiota (Snart et al., 2006; Abell et al., 2008; Mitsou et al., 
2010), some dietary fibers or whole grains may be more beneficial against obesity than others 
(Andersson et al., 2010). 
In this article, physiological interactions between the gut microbiota and the host will be 
reviewed, followed by a discussion on the role that dietary fiber and whole grains may play in 
improving the composition and function of the gut microbiota in obesity. 
1.3. Gut microbiota composition and contribution to obesity 
There are at least 1014 microorganisms in the human colon belonging to over 1000 species 
(Egert et al., 2006). Although the gut is essentially sterile at birth, it is rapidly populated with 
bacteria through environmental exposure (Palmer et al., 2007). Facultative and aerobic bacteria 
establish first, but are later overcome by more strict anaerobes as the environment in the colon 
becomes more reduced (Adlerberth and Wold, 2009). Ecological and evolutionary forces shape 
the microbial diversity in the human gut and lead to a stable microbiota in adults that is 
dominated by members of two bacterial phyla: Firmicutes and Bacteroidetes (Sekirov et al., 2010; 
Ley et al., 2006a; Neish, 2009).  
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Bacteriodetes and Firmicutes account for 90% of the total bacteria that are amplified 
from 16S RNA sequencing (Ley et al., 2006b). Bacteriodetes is a diverse gram negative bacterial 
phylum including four classes: Bacteroidia, Flavobacteria, Sphingobacteria, and Cytophagia, 
representing around 7000 different species. Most of them evolve with the host into a symbiotic 
relationship, functioning to degrade indigestible dietary carbohydrates (Michel et al., 2011) and 
host-derived carbohydrates such as mucins (Salyers et al., 1977). Short chain fatty acids (SCFAs), 
especially butyrate and succinate, are produced as the main fermentation metabolites, which play 
important roles in gut health (Kim and Milner, 2007).  Some species in this phylum, such as 
Bacteroides fragilis, also secrete various proteases (Gibson and Macfarlane, 1988), which result 
in undesirable fermentation products such as ammonia, hydrogen sulfide,  and phenol 
(Macfarlane and Macfarlane, 2012). Firmicutes is a gram positive phyla containing 3 classes: 
Bacilli, Clostridia, and Mollicutes, and 164 genera. Clostridial cluster IV and XIVa, which 
constitute more than 80% of total bacteria in this phyla (Duncan et al., 2007), are abundant 
fermenters of starch, fructans, and cellulose, with production of acetate, butyrate, and lactate. 
Peptococcus, Peptostreptococcus and Clostridum are the predominant proteolytic genera in this 
phylum (Dimitris Charalampopoulos and Rastall, 2009). 
The association between obesity and the gut microbiota composition was initially 
established with mouse models. Genetically obese, leptin-deficient mice showed 50% fewer 
Bacteroidetes accompanied by a proportional increase in Firmicutes compared with wild type 
counterparts (Ley et al., 2005). By exploring the effects of high-fat diets and genetic obesity on 
the gut microbiota over time, Murphy et al. (2010) found an increase in Firmicutes and decreases 
in Proteobacteria and Bifidobacterium spp. in both high-fat-fed wide-type and genetic ob/ob 
mice. Hildebrandt et al. (2009) reported that mice fed a high-fat diet for three months have higher 
Clostridiales and fewer Bacteroidetes.  
Since these discoveries, a number of studies have reported the differences in gut 
microbiota composition in obese states compared with normal weight states in humans (Table 
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1.1). Consistent with the mouse model data, the first human studies showed a higher proportion of 
Bacteroidetes in normal weight individuals compared with obese (Ley et al., 2006b; Schwiertz et 
al., 2009); however, others have reported more Bacteriodetes and an enrichment of hydrogen-
producing Prevotellaceae in obese individuals compared with normal weight (Zhang et al., 2009). 
Furet et al. (2010) showed lower Bacteroides-Prevotella and Faecalibacterium prausnitzii in 
obese subjects, while another study showed significantly higher Bacteroides in overweight 
women compared with normal-weight women (Collado et al., 2008). 
Upon weight loss in obese individuals, changes in the gut microbiota have been reported 
but are also not consistent (Table 1.1). For instance, Schwiertz et al. (2009) showed that the 
proportion of Bacteroidetes is reduced by weight loss. In contrast, Duncan et al. (2008) reported 
no change in Bacteroidetes after 4 weeks on a reduced carbohydrate diet, but did report a 
significant reduction in a group of butyrate producing Firmicutes in the obese group after diet 
intervention. In other studies, higher Bacteroides was associated with excessive weight gain 
(Collado et al., 2008), and weight loss was accompanied by an increase in Bifidobacteria 
(Santacruz et al., 2010).  
Many of these findings above were reported using methods that only amplify specific 
bacteria in the community. Thus, changes or shifts may have been present but not discovered or 
reported. Additionally, these methods have some inherent drawbacks that render the results only 
semi-quantitative. Accompanied by the complexity of the gut microbiota and the large differences 
among individuals, this may explain some of the inconsistencies in the gut microbiota 
composition in obesity and changes upon weight loss. 
1.4. Proposed mechanisms for the role of gut microbiota in obesity 
1.4.1. Modulating energy harvest from diet 
Compared with germ-free mice, conventional mice exhibit a greater ability to harvest 
energy from food, contributing to body weight gain (Backhed, 2004). Transferring the fecal 
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microbiota from obese mice into wide type, germ-free mice results in increased fat gain and 
dietary calorie extraction in the recipient compared to when fecal microbiota from normal weight 
mice are used, indicating more efficient energy extraction by the obese microbiota (Turnbaugh et 
al., 2006).  
A meta-genomic study showed that the gut microbiota are enriched in the genes involved 
in energy harvest in obese mice compared with lean mice (Lakhan and Kirchgessner, 2011). An 
enhanced expression hydrolases and lysases would lead to metabolism of undigested material that 
would, under normal circumstances, be inaccessible (Musso et al., 2010). This would result in 
higher SCFA production in obese states compared with normal weight, which can contribute to 
extra energy recovery for the host (Turnbaugh et al., 2006; Schwiertz et al., 2008), as well as 
reduced fecal energy content (Webb and Annis, 1983; Turnbaugh et al., 2006).  
This finding is peculiar considering that colonic fermentation of indigestible 
carbohydrates with accompanying SCFA production is generally recognized as beneficial to gut 
health (Campbell et al., 1997; Tedelind et al., 2007). Of note is that epidemiologic studies have 
consistently reported less dietary fiber intake in obese individuals compared with normal weight 
(Miller et al., 1994; Alfieri et al., 1995; Koh-Banerjee et al., 2004; Davis et al., 2006; Ben Slama 
et al., 2011). Although speculative, it may be that in obese states the gut microbiota are constantly 
starved for substrate and express more diverse enzymes so as to utilize every last bit of substrate 
available, even those that may result in undesirable fermentation products (Le Leu et al., 2006; 
Macfarlane and Macfarlane, 2012), leading to dysbiosis. Conversely, the relative abundance of 
dietary fiber substrate for normal weight individuals consuming adequate dietary fiber render the 
microbiota more selective in what they metabolize, leading to more beneficial fermentation 
products and higher fecal energy.   
Furthermore, although SCFAs contribute about 10% of total energy to the diet (McNeil, 
1984), they also influence hormones, which, in many cases, increase the feeling of satiety 
(McBurney et al., 1990; Tucker and Thomas, 2009), reduce absorption of energy, or reduce 
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energy storage (Table 1.2). For instance, SCFA (especially propionate and acetate) are ligands for 
GPR41, identified as a G protein-coupled receptor and expressed by a subset of enteroendocrine 
cells in the gut epithelium (Samuel et al., 2008). GPR41 expressed in human colonic mucosa may 
function as a sensor for luminal SCFAs (Tazoe et al., 2009). Upon ligand binding, these receptors 
stimulate secretion of the peptide hormones PYY and leptin that modulate gut motility and reduce 
energy harvest from diet. GPR41-deficient mice show a reduced expression of PYY (Samuel et 
al., 2008). Obese individuals have decreased serum leptin levels associated with increased hunger 
and reduced energy expenditure. Modulation of GPR41 is a potential therapeutic target to control 
energy extraction. 
Glucagon-like peptide-1 (GLP-1) is a key hormone released from enteroendocrine L-cells 
in the ileum and proximal colon (Drucker, 2006). Administration of GLP-1 can increase secretion 
of insulin from pancreatic b-cells (Baggio and Drucker, 2007) and induce satiety and weight loss 
in animals and humans. Increased fermentation of indigestible carbohydrate in the colon is 
associated with higher plasma GLP-1 by promoting L-cell differentiation in proximal colon 
(Turton et al., 1996; Piche et al., 2003; Cani et al., 2004; Cani et al., 2005). Some have postulated 
that this may be due to SCFA production from indigestible carbohydrate fermentation (Cani et al., 
2007b). It has been shown that butyrate enhances proglucagon gene expression and GLP-1 
content in immortalized colonic L-cells in vitro (Dumoulin et al., 1995; Pratt et al., 1996), and the 
SCFA receptor GPR43 is expressed on L-cells (Karaki et al., 2006). Therefore, sufficient 
production of butyrate might help increase GLP-1 production and be conductive to controlling 
body weight. 
The gut microbiota can modulate fat emulsification and absorption as well as lipid 
metabolism by influencing bile acid metabolism. In the small intestine, bile acids promote 
emulsification and micelle formation of dietary lipids and lipid-soluble vitamins, which is 
required for absorption (Ridlon, 2005). Approximately 400–800 mg of bile salts per day make 
their way to the colon and can be biotransformed by microbial enzymes and then delivered to the 
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liver where they become part of the bile acid pool (Matern and Gerok, 1979). Martin et al. (2007) 
found that, compared with conventional gut microbiota, colonization with human intestinal 
microbiota strains (high in Bacteroides and Enterobacteria)  was correlated with changes in the 
bile acid pattern toward tauro-conjugated bile acids and higher absorption of dietary lipids. 
Tauro-conjugated bile acids are more efficient at lipid emulsification and micelle formation 
compared with deconjugated bile acids (Armstrong and Carey, 1982; Heuman, 1989). They also 
found that Lactobacillus, Bifidobacteria and Enterobacteria, and Bacteroides might play an 
important role in the deconjugation process, thus resulting in less efficient dietary fat 
emulsification and absorption (Grill et al., 1995). Moreover, normal bile acids (i.e., unconjugated) 
have been associated with increased energy expenditure by promoting intracellular thyroid 
hormone activation (Watanabe et al., 2006).  
1.4.2. Influencing energy and fat utilization 
Gut microbiota also modulate energy and fat deposition by several pathways. Fast 
induced adipose factor (Fiaf), or angiopoietin-like protein 4, was first identified as a target gene 
of the nuclear receptor peroxisome proliferator-activated receptors (PPAR), which can stimulate 
fatty acid oxidation and prevent fat storage in both muscle and adipose tissue (Mandard, 2005). 
Backhed et al. (2007) demonstrated that germ free knockout mice lacking Fiaf are not protected 
from diet-induced obesity and colonizing germ-free mice with gut microbiota leads to decrease 
the expression of Fiaf.  
Another enzyme related to fat oxidation and storage is AMP-activated protein kinase 
(AMPK), which may initiate fatty acid oxidation in peripheral tissues of muscle and liver by 
phosphorylating acetyl CoA carboxylase and decreasing glycogen storage (Mandard, 2005). 
Active-AMPK is 40% higher in germ free animals compared with conventional animals. The gut 
microbiota can suppress skeletal muscle fatty acid oxidation in an AMPK-related metabolic 
pathway, although the exact pathway whereby the microbiota signals AMPK remains unclear 
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(Tilg and Kaser, 2011). Thus, the gut microbiota may play a role in controlling energy 
homeostasis and nutrient availability.       
1.4.3. Modulation of low grade inflammation 
Obesity has been linked to low grade chronic inflammation (Wellen, 2005). Bacterial 
lipopolysaccharide (LPS), which is produced upon the death and translocation of gram-negative 
bacteria in the gut, has been identified as a triggering factor in the onset of systemic inflammation 
(Cani et al., 2007a). An increase in plasma LPS concentration could be induced by high-fat 
feeding. Mice fed for 4-weeks with a high-fat diet had plasma LPS levels two to three times 
higher than normal, and exhibited obesity and insulin resistance accompany by metabolic 
endotoxemia (Cani et al., 2007a). Bifidobacteria have been shown to reduce intestinal LPS and 
fortify intestinal barrier function, indicating that composition of gut microbiota is related to 
inflammation and obesity (Griffiths et al., 2004). 
 Besides the mechanisms discussed above, it has also been proposed that the gut 
microbiota could decrease body weight by placing an additional energetic burden on the host. The 
underlying mechanism may involve stimulating synthesis of new gut tissue, adjusting 
inflammation or activating host defense system (Flint, 2011). Nevertheless, it is increasingly clear 
that the gut microbiota play roles in energy hemostasis and weight loss, although the exact roles 
and the specific microbial taxa involved remain elusive. 
1.5. Dietary intervention as a treatment to modify the gut microbiota in obesity 
  A number of studies (Duncan et al., 2008; Santacruz et al., 2009) have shown that the diet 
is an important and fundamental promoter of differences in gut bacterial composition and 
diversity. Dietary fiber serves as the main source of energy for gut bacteria, and dietary 
intervention can change the microbiota composition to a healthier state (Jenkins et al., 1987). 
Thus, dietary fiber and foods high in dietary fibers, such as whole grains, fruits, and vegetables, 
are intriguing candidates for correcting the dysbiosis in obese states and promoting weight loss. 
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1.5.1. Dietary fiber 
 In 2008, the Codex Commission on Nutrition and Foods for Special Dietary Uses 
(CCNFSDU) gave the definition of dietary fiber as carbohydrate polymers with 3-9 monomeric 
units, which are not hydrolyzed by endogenous enzymes in the small intestine of human beings 
and belong to the following three categories: 1) edible carbohydrate polymers naturally occurring 
in food, 2) carbohydrate polymers that have been obtained from raw material in food by physical, 
enzymatic, or chemical means and which have been shown to have physiological of benefit to 
health, and 3) synthetic carbohydrate polymers that  have been shown to have physiological effect 
of benefit to health (Raninen et al., 2011). 
  Dietary fiber can be divided into two classes based on solubility in water: soluble dietary 
fiber and insoluble dietary fiber. Pectin, guar gum, soluble β-glucan, and polysaccharide gums are 
examples of soluble dietary fiber. Soluble dietary fiber shows favorable effects on controlling 
glucose level and lipid metabolism homeostasis, mainly due to an increased viscosity in luminal 
contents (Galisteo et al., 2008). Hemicellulose, cellulose and lignin are among the common 
insoluble dietary fibers, which promote fecal bulking, softening and laxation. Both soluble and 
insoluble dietary fibers can be fermented by gut microbiota in colon and yield SCFAs, although 
soluble generally results in comparatively more rapid and higher concentrations of SCFAs.  
According to the International Scientific Association of Probiotics and Prebiotics, “a 
dietary prebiotic is a selectively fermented ingredient that results in specific changes, in the 
composition and/or activity of the gastrointestinal microbiota; thus conferring benefit(s) upon 
host health” (Ley, 2005). Most research has been focused on selective stimulation of 
Bifidobacteria and Lactobacilli by oligosaccharides (Depeint et al., 2008; Holma et al., 2002; 
Kolida et al., 2002). These products may also result in beneficial physiological effects not only in 
colon, but systemically through prevention of inflammation (Ewaschuk and Dieleman, 2006), 
immune modulation (Bodera, 2008), and energy metabolism (Woods, 2005).  
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Epidemiological studies show a significant inverse association between dietary fiber 
consumption and body mass index (BMI; McBurney et al., 1990; Tucker and Thomas, 2009). In 
203 healthy men, intakes of complex carbohydrate and dietary fiber were associated with lower 
body fat, especially in the highest body fat groups (Nelson and Tucker, 1996). In another study, 
higher dietary fiber consumption was correlated with reduced body weight and fat in women 
(Tucker and Thomas, 2009). Combined with other studies, epidemiological studies convincingly 
indicate an inverse association between dietary fiber intake and body weight (Howarth et al., 
2001). 
A number of mechanisms describing how dietary fiber might reduce obesity have been 
proposed. Dietary fiber can promote the feeling of satiety compared with starch and simple sugars 
(Connolly et al., 2010; Dunne et al., 2001; Pereira and Ludwig, 2001). Increasing satiety may 
result from several factors including the intrinsic properties of dietary fiber (high viscosity, 
bulking and gel formation), which can reduce the rate of gastric emptying and macronutrient 
absorption, and effects on certain gut hormones [PYY, ghrelin and cholecystokinin (CCK)] that 
can signal satiation (Woods, 2005). Additionally, high fiber foods are less energy dense compared 
with high fat and high protein food. Thus, high fiber foods can displace energy so as to reduce 
body weight. High fiber foods in general also do not promote rapid fluctuations in blood glucose 
levels (Giacco et al., 2000).  
In spite of the convincing role of dietary fiber in preventing obesity suggested by 
epidemiological studies and proposed mechanisms, intervention studies on weight loss and 
dietary fibers intake are inconsistent. Birketvedt et al. (2000) found that increased dietary fiber 
intakes were associated with body weight loss, while, in a pilot study (Howarth et al., 2003), 
dietary administration of fermentable and non-fermentable fiber did not change body weight. 
Moreover, other intervention studies have failed to demonstrate a clear change in satiety upon 
dietary fiber supplementations (Smith and Tucker, 2011). One mechanism that has not been 
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thoroughly explored is the influence of dietary fibers on the gut microbiota in obesity and how 
they may modulate the microbiota to a composition that is more conducive to weight loss.  
Different dietary fibers show quite different fermentation impacts on gut bacteria. For 
instance, Bifidobacteria and Lactobacilli cannot ferment cereal β-glucan alone in vitro but can 
utilize oligosaccharides resulting from its partial hydrolysis (Crittenden et al., 2002). In contrast, 
Bifidobacterium longum and Bifidobacterium adolescentis can ferment long chain arabinoxylan 
(AX) in vitro from a variety of cereals without pre-hydrolysis. It is likely that different dietary 
fibers are more effective than others at modulating obesity since dietary fiber is a complex class 
of compounds (Table 1.3). 
Fructans 
Fructan is a general term for a wide variety of carbohydrate such as fructooligosacchrides 
(FOS), oligofructose, and inulin, depending on degree of polymerization (DP). Fructans reach the 
large colon and undergo fermentation by gut microbiota. FOS with low DP are mostly fermented 
in the proximal colon, while some inulin and fructans with longer DP may reach more distal 
regions of the colon (Alles et al., 1996). The primary effect of inulin type prebiotics on gut 
ecology is the stimulation of bifidobacterial growth (Roberfroid, 2007). By adding 15 g inulin/d 
to the diet for 15 days, Bifidobacteria increase by 1 log compared to the baseline (Liu, 2007). 
Inulin-type fructans may have an influence on weight loss, although research in this area is very 
limited. One dietary intervention study with 97 adolescents demonstrated a significant reduction 
in weight gain for the people receiving 8g/d oligofructose-enriched inulin compared with 
maltodextrin as a control for a year; the difference disappeared one year after the supplementation 
was stopped (Abrams et al., 2007).  
Resistant starch    
Some starch may escape digestion in the human small intestine and reach the colon to be 
fermented by gut bacteria. Resistant starch (RS) can be classified into 4 main types: physically 
inaccessible starch (RS-1), resistant granules and high amylose starches (RS-2), retrograded 
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starches (RS-3) and chemically modified starches (RS-4; Bird et al., 2000). Fermentation of RS, 
especially by RS-2, has been shown to increase the production of butyrate. However, Ferguson et 
al. (2000) showed that fermentation of resistant starch from potato yields more butyrate than high 
amylose corn starch. Another study showed that RS-4 but not RS-2 leads to profound phylum-
level changes, significantly increasing Actinobacteria and Bacteroidetes while decreasing 
Firmicutes (Martínez et al., 2010). These studies indicate that differences exist in the 
fermentation properties of different type of RS, even though they are the same chemical structure. 
With regard to obesity, some studies show that inclusion of RS in the diet can reduce body fat by 
energy dilution and changing expression of PYY and GLP-1 (Keenan et al., 2006; Shen et al., 
2008). Another study found that, compared with the control (0% resistant starch), administration 
of 5.4% resistant starch significantly increased lipid oxidation (Higgins et al., 2004), thereby 
reducing the fat accumulation. 
Arabinoxylan 
AXs are the most abundant non-digestible carbohydrates present in most cereals. AX can 
be divided into water-extractable (WE-AX) and water-unextractable (WU-AX) according to 
extractability in water, as well as arabinoxylan oligosaccharides (AXOS), which are hydrolysis 
products of AX. Branching, molecular weight, and cross-linking with other components 
contribute to their solubility (Neukom, 1973). AXs are broken down in the colon by intestinal 
bacteria that express AX-degrading enzymes such as xylanases and arabinofuranosidases (Hughes 
et al., 2007). Fermentation of AX by human intestinal bacteria in vitro is associated with a higher 
proportion of propionate production compared with other dietary fibers (Amrein et al., 2003; Van 
Laar et al., 2002). High fat mice supplemented with WE-AX, have shown increases in clostridial 
cluster XIV, Bacteroides-Prevotella spp., and Bifidobacteria accompanied by reduced circulating 
inflammatory markers, body weight, and hepatic cholesterol-lowering effects (Brennan et al., 
2011). WE-AX of different molecular weights and cross-linking can affect selectivity toward 
certain bacterial groups. Fermentation of a 66 KDa WE-AX from wheat particularly aided in the 
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growth of Lactobacilli and Eubacteria, while other WE-AX fractions (278, and 354 KDa) only 
increased Eubacteria (Hughes et al., 2007). WE-AX cross-linked with ferulic acid resulted in a 
slower fermentation rate than non-cross-linked WE-AX, the latter of which has also been 
correlated to increases in Bacteroides fragilis in vitro (Hopkins et al., 2003). WU-AX are only 
partially fermented in the colon, but stimulate butyrate and butyrate-producing bacteria such as 
Roseburia/E. rectale spp. (Damen et al., 2011). Fermentation of AXOS can reduce the pH and 
significantly increase the Bifidobacteria more so than WE-AX and WU-AX. Some research 
suggests that fermentation of AXOS has stronger ability to stimulate Bifidobacteria than fructans 
(Hsu et al., 2004). 
β-Glucan 
Mixed linkage (1, 3 and 1, 4) β-glucans are a ubiquitous group of nonstarch 
polysaccharides in cereal grains, but are found in the highest concentrations in oats and barley (El 
Khoury et al., 2011). Other sources of β-glucan are the cell walls of yeast, fungi, and some 
bacteria (Volman et al., 2008). β-Glucan has been demonstrated in clinical trials to significantly 
impact weight loss by increasing satiety, influencing absorption efficiency in small intestine and 
lowering cholesterol (Huang et al., 2011; Kim et al., 2006; Rondanelli et al., 2011). In addition, 
β-glucan has been documented to increase insulin sensitivity (Ximenes et al., 2007). The health 
benefits of β-glucan in the gastrointestinal tract, such as increasing satiety and reducing blood 
serum cholesterol and blood glucose, are correlated with molecular weight distribution and 
viscosity. The few studies evaluating the influence of β-glucan on the gut microbiota have 
suggested that it exhibits only moderate influences on the gut microbiota compared with 
prebiotics such as inulin (Hughes et al., 2008; Jha et al., 2011; Lin et al., 2011; Mitsou et al., 2010; 
Pieper et al., 2008). However, an increase in Bifidobacteria compared with none detected at 
baseline and significant increase of Bacteroides were observed by dietary intervention with β-
glucan (Mitsou et al., 2010).  
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1.5.2. Whole grain  
             Evidence continues to mount that whole grains can protect people from many chronic 
diseases including obesity, cardiovascular disease, and type-2 diabetes (Quigley, 2011). Whole 
grains are defined as “intact ground cracked or flacked caryopsis, whose principal anatomical 
components—the starchy endosperm, germ, and bran—are present in the same relative 
proportions as they exist in the intact caryopsis” (Force, 1999). The Whole Grains Council notes 
that, “if the grain has been processed (e.g. cracked, crushed, rolled, extruded, and/or cooked), the 
food product should deliver approximately the same rich balance of nutrients that are found in the 
original grain seed” (WGC, 2004). 
 Epidemiological studies have found there is an inverse relationship between 
consumption of whole grain and obesity. For instance, in three studies based on food frequency 
questionnaires encompassing 3559 participants, whole grain intake was inversely related to body 
weight gain and waist-to-hip ratio (McKeown et al., 2002; Newby et al., 2003; Rose et al., 2007b). 
Increased consumption of whole grain was also correlated with lower BMI and waist 
circumference in the analysis of the data from 1999-2004 NHANES containing 13,000 adults 
from 19-50 years old (O'Neil et al., 2010). In a study using nationally representative samples of 
adults living in Great Britain from 1986–1987 and 2000–2001, an inverse association between 
whole grain intake and obese population was observed in 1986-1987 (Thane et al., 2007). 
Another study that compared whole and refined grain consumption showed that both 
subcutaneous and visceral adipose tissue were inversely associated with whole grain intake, while 
positively associated with refined grain intake (McKeown et al., 2010). 
Data from intervention studies have not totally supported results from epidemiological 
studies. Katcher et al. (2008) examined 50 obese men and women with metabolic syndrome who 
received whole grain cereal for 12 weeks and showed significant decreases in both body weight 
and percent body fat. However, in an intervention study on 64 healthy men and women for 4 
weeks, no relationship between whole grain cereal consumption and body weight loss was 
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observed (Waller et al., 2004). Furthermore, Brownlee (2009) did not find a significant 
association between whole grain intake and body weight when 361 overweight participants were 
supplemented with whole grains in the diet (60 -180 g/day).  
            Mechanisms have been proposed relating to the protection of whole grains against obesity. 
These include the influence of the dietary fiber component discussed above, but also include the 
influence of antioxidants and other phytochemicals present in whole grain that have been shown 
to be involved signaling for many metabolism pathways (Fardet, 2010). 
 Influence of whole grain on the gut microbiota in obesity is an unexplored area of 
research. Whole grain intake has been associated with reduced distal colonic pH (Sengupta et al., 
2001). This may be due to the prevalence of insoluble dietary fiber in whole grains. Insoluble 
dietary fiber is largely responsible for supporting bacterial metabolism in the distal colon due to 
its slower fermentation rate (Leach, 2006). This may be important for preventing low-grade 
inflammation in this region, which is a factor in obesity.  
 Dietary fiber from whole grain can impact gut microbiota. For instance, in vitro, 
Bifidobacterium longum and B. adolescentis can ferment AX (Crittenden et al., 2002), while 
these substrates cannot be fermented by potentially harmful bacteria such as Escherichia coli, 
Clostridium perfringens, or C. diffcile (Oikarinen et al., 2007). Cellulolytic bacteria such as those 
belonging to clostridial cluster IV have been shown to possess the enzymes and ability to degrade 
cellulose (a major component in whole grains). Recently discovered species, Bacteroides 
cellulosilyticus, has the strong ability to break down insoluble cellulose (Robert and Bernalier-
Donadille, 2003; Robert et al., 2007; Wedekind et al., 1988), producing SCFA and lowering the 
pH in the colon. Therefore, whole grains may have their unique health benefits including 
prolonging / sustaining the fermentation profile and selectively stimulating certain bacteria by 
providing fermentable substrates to the gut microbiota. 
Notably, all whole grains are not identical (Table 1.4) and thus may result in different 
physiological effects. If one whole grain is more effective at preventing obesity than others, 
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recommendations for food intake could be tailored to include foods high in this grain for 
prevention or treatment of obesity. For instance, Andersson et al. (2010) fed mice whole grain 
wheat or whole grain rye for 22 weeks and found that rye reduced body weight, adiposity, and 
total plasma cholesterol and improved insulin sensitivity compared with wheat. This may be 
because rye is the highest in water extractable AX among other cereal grain, since AX 
supplements have been shown to decreased adipocyte size and inflammation (Neyrinck et al., 
2011). 
 Grains also contain unique bioactive phytochemicals including derivatives of benzoic and 
cinnamic acids, anthocyanidins, quinones, flavonols, chalcones, flavones, flavanones, and 
phenolic compounds (Adom and Liu, 2002). It has been shown that these antioxidants might 
protect the gut epithelial cell, prevent inflammation, and reduce the intensity of diabetes 
(Balasubashini et al., 2004; Slavin, 2007). Most of these components are present in the germ/bran 
fraction. For instance, 83% of total phenolic content, 79% of total flavonoid content are 
concentrated in the bran/germ fraction of wheat (Liu, 2007). Most of these compounds are bound 
to cell wall material and can resist digestion in the small intestine and reach colon, where gut 
microbiota can convert these compounds to their metabolites such as phenolic acids or lactone 
structures (Aura, 2008). Andreasen et al. (2001) demonstrated that human and rat colonic 
microbiota have the ability to release diferulic acids from dietary cereal bran. Upon releasing, 
ferulic acids rapidly become bioavailable to the host, resulting in alleviating oxidative stress 
during inflammation such as in obesity (Huang F et al., 2011).  
 Whole grains can contain other bioactive components that may affect physiological 
properties. For instance, wheat bran contains at least twice as much betain than oats, while corn 
contains no betain. Betain has been linked to metabolic syndrome, lipid disorder and diabetes 
(Lever and Slow, 2010; MacKay et al., 2010). Oats contain unique, anti-inflammatory 
compounds called avenanthramides have been shown to reduce proliferation of colonic cancer 
cell (Guo et al., 2010). Although the protective effect of avenanthramides on obesity remains 
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unknown, avenanthramide extracts from oats have been shown to inhibit LDL (low density 
lipoprotein) oxidation, which protects against atherosclerosis (Dykes and Rooney, 2007). 
1.6. Conclusion 
Recent evidence suggests that both compositional and functional differences in gut 
microbiota exist in lean and obese individuals. The human gut microbiota can influence energy 
harvest and energy expenditure of the host. Recent mechanistic studies in animal and human 
models have provided insight into the proposed contributory role of the gut microbiota in energy 
metabolism and weight control. Modulation of the gut microbiota composition or its biochemical 
capacity may be facilitated by dietary intervention. Considering the unique chemical and 
physiological properties of whole grains and dietary fiber, these compounds may serve as 
important candidates for dietary intervention to elicit beneficial effects especially by altering 
obese type gut microbiota to a healthier state. Research initiatives to establish the 
interrelationship among whole grains and dietary fibers, the gut microbiota, and the metabolism 
of the host are needed. 
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Table 1.1. Differences in fecal gut microbiota composition in obese and normal weight individuals.a 
Subjects Dietary intervention Method Differences between normal weight and obese 
Changes upon weight loss in 
obese subjects Reference 
12 obese participants 
for one year (2 lean 
controls) 
On a fat restricted diet 
(30% calories from fat) or 
carbohydrate restrict diet 
(25% calories from 
carbohydrate) with total 
calories 1200-1800 kcal/d. 
16S rRNA 
sequencing  
Higher Firmicutes: Bacteroidetes 
ratio in obese compared with 
lean individuals at baseline 
Increase in proportion of 
Bacteroidetes with weight loss 
Ley et al., 
2006 
15 obese and 14 
normal weight for 8 
weeks 
Reduced carbohydrate 
weight-loss diet 
FISH  No difference between BMI and 
relative population of 
Bacteroidetes  
Significant reductions in a 
group of butyrate-producing 
Firmicutes in obese subjects on 
weight lose diet; no association 
between weight loss and 
population of Bacteroidetes 
Duncan et 
al., 2007 
18 overweight and 36 
normal weight 
women 
No intervention FISH and RT-
PCR  
Bacteroides and Staphylococcus 
were significantly higher in the 
overweight state than in normal-
weight women 
 Collodo et a 
al ., 2008  
25 obese; 25 
overweight; 24 
normal weight 
children at 7 years of 
age 
No intervention RT-PCR  More Bifidobacteria in  infancy  
contribute to normal weight; 
overweight was related to more 
Staphylococcus aureus in the 
fecal sample during infancy 
 Kalliomaki 
et al., 2008 
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Table.1.1 (continued). Differences in fecal gut microbiota composition in obese and normal weight individuals.a 
Subjects Dietary intervention Method      Difference between  normal      weight and 
obese 
Changes upon weight loss in 
obese subjects 
Author 
39 obese and normal 
weight individuals for 
10 weeks 
Energy restrict diet 
(calorie reduction =10–
40%) and a physical 
activity program  
FISH  Reduction of E. rectale-C. 
coccoides and C. histolyticum 
proportions with weight loss 
Nadal et 
al ., 2009 
23 subjects 
(BMI=29.4-35.2) 
Calorie-restricted diet 
(calorie reduction =10-
40%) and increased 
physical activity 
RT-PCR  Increased Bacteroides fragilis 
and Lactobacillus groups, 
decreased Clostridium 
coccoides and B. longum in 
high weight loss compared with 
moderate weight loss group 
Santacruz et 
al ., 2009 
33 obese; 35 
overweight; 30 lean 
individuals 
No intervention RT-PCR  Firmicutes:Bacteroidetes ratio 
was lower in overweight and 
obese compared with normal 
weight 
 Schwiertz 
et al ., 2009 
3 morbidly 
obese(BMI>35); 3 
normal weight; 3 post 
gastric bypass surgery 
No intervention 454 
pyrosequencing 
/RT-PCR  
More Bacteriodetes in obese 
than normal individuals; 
Prevotellaceae enriched in 
obese subjects compared with 
normal weight 
 Zhang et 
al ., 2009 
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Table.1.1 (continued). Differences in fecal gut microbiota composition in obese and normal weight individuals.a 
Subjects Dietary intervention Method       Difference between  normal      
weight and obese 
Changes upon weight loss in 
obese subjects 
Author 
30 obese individuals 
with type-2 diabetes 
and 13 lean control 
No intervention RT-PCR  Bacteroides-Prevotella and 
Faecalibacterium prausnitzii 
were lower in obese subjects 
 Furet et al ., 
2010 
16 overweight and 34 
normal weight 
No intervention RT-PCR  Bifidobacterium and 
Bacteroides were inversely 
associated with body weight, 
whereas an opposite trend was 
found for Staphylococcus, 
Escherichia coli, and 
Enterobacteriaceae 
More Bifidobacterium in 
women with normal weight 
gain than excessive weight gain 
during pregnancy 
Santacruz et 
al ., 2010 
aNormal weight [body mass index (BMI) <25]; overweight (25<BMI<30); obese (BMI>30); FISH: fluorescence in situ hybridization. 
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Table 1.2.  Hormones influenced by the gut microbiota and their metabolites. 
Hormone  Description and function of hormone 
Influence on metabolic 
function Influence by  gut microbiota References 
 Peptide 
YY (PYY) 
Enteroendocrine cell-
derived hormone; may 
be involved in 
reducing appetite 
Decreased PYY increase gut 
motility and transit rate; 
increase energy harvest 
Gnobiotic mice (GPR41-
deficient) colonized with 
Bacteroides thetaiotaomicron 
and Methanobrevibacter 
smithi show decreased PYY 
Woods, 
2005; 
Samuel et 
al., 2008  
 
Fast-
induced 
adipose 
factor 
(Fiaf) 
Angiopoietin-like 
protein 4; expressed 
primarily in adipose 
tissue and has 
endocrine function 
Reduced Fiaf results in 
increased lipoprotein lipase, 
aiding in triglyceride storage 
Fiaf can be selectively 
suppressed by gut microbiota 
Mandard, 2005 
AMP-
activated 
protein 
kinase 
(AMPK) 
Initiates fatty acid 
oxidation 
Suppression of AMPK 
initiates fatty acid oxidation in 
peripheral tissues of muscle 
and liver 
Microbiota can suppress the 
activity of AMPK 
Tilg and Kaser, 
2011 
Glucagon-
like 
peptide 1 
(GLP-1) 
Key hormone released 
from enteroendocrine 
L-cells; promotes 
satiety 
Increase glycogen synthesis in 
muscle cells and promotes 
satiety  
Increased by fermentation of 
dietary fiber by gut 
microbiota and butyrate 
production 
Baggio and 
Drucker, 
2007 
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Table 1.3. Composition of different dietary fibers and their impact on gut microbiota. 
Dietary fiber Types Structure Impact on gut microbiota Other health benefits References 
Arabinoxylan 
(AX) 
Water-extractable; 
water un-extractable; 
arabinoxylan 
oligosaccharide (AXOS) 
(1→4)-linked β-D-
xylopyranosyl 
residues substituted 
with α-L-
arabinofuranosyl 
residues  
AX from wheat increase 
clostridial cluster XIV , 
Bacteroides, Prevotella spp; 
AXOS are strongly 
bifodogenic 
Anti-inflammatory and 
anti-obesity effects; 
lower postprandial 
responses in serum 
glucose, insulin and 
triglycerides (AXOS) 
Van Craeyveld et al., 
2008;Van den 
Abbeele et al., 2011  
β-Glucan (mixed 
linkage) 
 Liner chain of (1→4)- 
and (1→3)-linked β-
D-glucopyranosyl 
residues 
Increase C. histolyticum, and 
to a lesser extent clostridial 
cluster IX and the 
Bacteroides–Prevotella and 
Atopobium groups; moderate 
increase in propionate and 
butyrate 
Increase satiety; reduce 
blood serum cholesterol 
and blood glucose 
Snart et al., 2006; 
Hughes et al. 2008; 
Mitsou et al., 2010b 
Fructans  Inulin, oligofructose, 
fructooligosaccharides 
(FOS) 
 (2→1)-linked β-
fructofuranosyl  
residues with a 
terminal α-D-
glucopyranosyl 
residue 
Stimulation of Bifidobacteria 
growth  
Increase calcium 
absorption; influence 
aspects of immune 
response in infants; 
therapeutic benefits in 
animal models of colitis 
Kelly, 2008 
Resistant starch RS1 (physically 
inaccessible), RS2 
(native granular), RS3 
(retrograded), RS4 
(chemically modified) 
Linear or branched 
chain of (1→4)- and 
(1→6)-linked α-D-
glucopyranosyl 
residues 
High butyrate production; 
reduce production of toxic 
metabolites; RS-2 increase 
the phylotypes related to 
Ruminococcus bromii; RS-3 
increased Lactobacillus; RS-
4 increase Actinobacteria and 
Bacteroidetes, while 
decreasing Firmicutes 
RS maintain blood 
glucose 
Behall, 2006; Abell et 
al., 2008; Siew-Wai et 
al., 2010 
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Table 1.3 (continued). Composition of different dietary fibers and their impact on gut microbiota. 
Type Types Structure Impact on gut microbiota Other health benefits References 
Glactooligosac-
crides (GOS) 
Human milk 
oligosaccharides 
(HMOs) and 
synthesized GOS 
Synthesized GOS: A 
chain of galactose 
units containing (1→
4), (1→3), and (1→
6)-linkages with 
terminal glucose unit; 
HMOs: sialyic acid, 
fucose, 2-amino-
glucuronic acid, 
glucose, and galactose 
with complicated 
linkages 
Increased Bifidobacteria 
and Lactobacilli; decreased 
Bacteroides 
Increased mineral 
absorption 
Ben et al., 2008 
Guar gum  A linear chain of (1→
4)-linked mannose 
backbone and (1→6)-
linked galactose 
branch chain 
Increase in fecal 
Bifidobacteria  compared 
with pectin  
Increase satiety and 
delay gastric emptying  
Noack  et al., 1998 
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Table 1.4. Selected composition of different whole grains. 
Grain 
Dietary fiber composition (% dry basis) Phenolic acids 
(mg/g) Notes References Arabinoxylana β-Glucan Cellulose Total 
Wheat 6-7 (25) 1 1.6-2.4 14.6 1.3 Highest betain content Kulp and Ponte, 2000 
Barley 
(hulless) 
3-7 (14) 3-11 0.7-1.3 19.3-22.6 0.45-1.3 High in β-glucan Delcour and Hoseney, 
2010 
Rye 6.5-12.2 (40) 1.9-2.9 1.3-1.9 14.6 1.4 Generally highest in 
WE-AX among whole 
grains 
Kulp and Ponte, 2000 
Oats (hulless) 1.2-2.9 (25) 4-6 0.8-2.0 9.6 0.47 Highest oil content; high 
in β-glucan; contains  
avenanthramides 
Kulp and Ponte, 2000; 
Dykes and Rooney, 
2007. 
Corn 1-2 -b 1.9-2.5 13.4 0.60 Arabinoxylan contains 
more oligosaccharide 
branches compared with 
other whole grains 
Delcour and Hoseney, 
2010 
Brown rice 2.64 (2.3) 0.11 1.4 3.9 0.20-0.38 High in phytosterols like 
oryzanol 
Kulp and Ponte, 2000; 
Biliaderis and 
Izydorczyk, 2007 
Sorghum (red) 1.8 (4.4) 0.9-3.15 2.7 10.1 0.39-0.75 Some cultivars contain 
condensed tannins  
Bach et al., 1988;Kulp 
and Ponte, 2000; 
Delcour and Hoseney, 
2010 
Pearl millet 2-3 - 3 8.5 0.61-3.9 Highest calcium content 
among all cereal 
Malathi and 
Devegowda, 2001; 
Falasca, 2009; Delcour 
and Hoseney, 2010; 
(Dendy, 1995) 
a Parenthetic numbers indicate the approximate percentage of total arabinoxylan than is water-extractable; the remainder is water-unextractable. 
b the component is not reported.
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CHAPTER 2. IMPACT OF SELECTED DIETARY FIBERS ON GUT MICROBIOTA 
SHORT CHAIN FATTY ACID PRODUCTION AND CARBOHYDRATE 
UTILIZATION 
2.1. Abstract 
Aberrant gut microbiota have been associated with many metabolic diseases. Dietary 
fibers are an important promoter of differences in gut bacterial diversity. Few studies have 
assessed the impact of specific dietary fibers on gut microbial communities. Six dietary fibers 
[pectin, guar gum, inulin, arabinoxylan, β-glucan, and resistant starch type 2 (RS-2)] were subject 
to in vitro digestion and fermentation using fecal samples collected from 15 individuals. 
Pyrosequencing was used to assess the impact of dietary fibers on the gut microbiota community. 
Short/branched chain fatty acids and carbohydrate utilization were correlated with levels of 
bacterial taxa. RS-2 caused the most dynamic change of the whole microbiota community. 
Bifidobacterium increased almost 10-fold on pectin substrate compared with the control. A 
reduction in Clostridiales was detected on all dietary fiber substrates. Ruminococcus significantly 
increased on all substrates expect RS-2 and pectin. Bacteroides exhibited positive correlation 
with propionate (r=0.52, p<0.01), while Ruminococcaceae and Faecalibacterium displayed 
positive correlations with butyrate production (r=0.39, 0.54, p<0.01). A negative correlation was 
detected between inulin utilization and Subdoligranulum (r=-0.74, p=0.004) while a strong 
positive relationship was shown between β-glucan utilization and Firmicutes (r=0.73, p=0.0019). 
Fecal samples were also divided into two groups based on whether the donor was normal weight 
[body mass index (BMI) <25; n=7] or obese (BMI>30; n=8). Incertae Sedis XIV (p<0.0001), 
Lachnospiraceae (p<0.04), and Ruminococcus (p<0.0001) were significantly reduced in the obese 
compared with the normal weight group. Obese and normal weight microbiota responded in 
different fashions on each dietary fiber except RS-2, leading to different shifts in certain taxa.   
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2.2. Introduction 
  The human gut harbors a complex microbial community, referred to as the gut microbiota. 
There are at least 1014 microorganisms in the human colon belonging to over 1000 species (19).  
The genome size of the gut microbiota exceeds that of human genome by 100-fold, providing 
many metabolic functions that cannot be achieve alone (72).  The gut microbiota has been linked 
to immune system development, protection from pathogens, and  metabolic  processes (66).  
 The importance of maintaining a “healthy” gut microbiota has been recognized. 
Aberrations in the gut microbiota, or dysbiosis, may lead to many metabolic diseases such as 
colon cancer, inflammatory bowel disease, type 2 diabetes, and obesity (44, 53). However, the 
underlying roles and functionality of specific bacteria relative to disease remain unclear (23). 
Numerous studies (18, 42, 63) have shown that the diet is an important and fundamental 
promoter of differences in gut bacterial composition and diversity. One of the most promising 
means of manipulating the composition of the gut microbiota is with dietary fibers, which are the 
major source of energy for the gut microbiota. Because dietary fibers are a broad class of 
compounds with varying health benefits, certain dietary fibers can elicit differing effects on the 
gut microbiota. For instance, water extractable arabinoxylan (WE-AX), the most abundant non-
digestible carbohydrates present in cereal grains, can be primarily fermented in the transverse 
colon and induce an increase in clostridial cluster XIV, Bacteroides-Prevotella spp., and 
Bifidobacteria accompanied by reduced circulating inflammatory markers, body weight, and 
hepatic cholesterol in mice (6). On the other hand, fructan generally supports an increase in 
Bifidobacteria, with numerous studies demonstrating its positive effects on obesity (49), diabetes 
(10), cancer (67), and other complications (38). Fermentation of resistant starch (RS) results in 
high production of butyrate (40) and RS4 (chemically modified starch) but not RS2 (high 
amylose starch) leads to increases in Actinobacteria and Bacteroidetes accompanied by decreases 
in Firmicutes (1).  
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Few studies have been performed to assess the impact of specific dietary fibers on gut 
microbial communities, especially using methodologies that amplify all bacteria in the 
community rather than pre-determined groups. Therefore, in the present study, pyrosequencing 
was used to determine shifts in the gut microbiota upon in vitro fermentation with different 
dietary fibers. The major metabolites [(short chain fatty acids (SCFA) and branched chain fatty 
acids (BCFA)] and carbohydrate utilization of bacteria were quantified and correlated with 
abundance of specific gut bacterial taxa to elucidate specific bacterial populations that play a role 
in the fermentation. Furthermore, because of potential differences in the gut microbiota between 
obese and normal weight individuals (41, 71), we also characterized differences in how the fecal 
microbiota from these two groups of people respond to each dietary fiber.  
2.3. Materials and methods 
2.3.1. Fecal samples 
Twenty fecal samples were obtained from Rush University Medical Center (Table 2.1). 
Donors were identified from the university’s patient database as having no known gastrointestinal 
disorders and having avoided antibiotics for 3 months prior to the study. Fecal samples were 
collected through a specimen hat inserted under the toilet seat, and then immediately transferred 
to gas-tight bags containing an Anaerocult C strip (BD GasPak Anaerobe Pouch system with 
indicator, NJ, USA), which created an anaerobic environment. Stools were stored at -80 °C until 
collection was complete, and then shipped overnight to the University of Nebraska-Lincoln on 
dry ice where they were further stored (-80 °C) until fermentation experiments were performed. 
Collection of these samples was approved by Rush University’s Institutional Review Board 
(#10062307-IRB02). 
Five fecal samples were excluded from the study. This is because with 15 donors we had 
120 samples {[15 donors*(6 dietary fibers+1 control)] +15 fecal samples}, which was the 
maximum that could be accommodated in 1 pyrosequencing run and still give sufficient depth to 
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the data. Because we anticipated not only analyzing the differences among dietary fiber 
treatments, but also between obese and normal weight individuals, we excluded the three fecal 
samples from donors that were in the overweight category [body mass index (BMI) between 25 
and 30] and the two from donors with the lowest BMIs in the obese category (BMI=31.4 and 
31.7). This provided us with 7 fecal samples from normal weight individuals and 8 fecal samples 
from obese individuals with the greatest difference in BMI between the two groups. 
2.3.2. Dietary fibers  
Guar gum and pectin were obtained from TIC Gums (White Marsh, MD, USA). Organic 
agave inulin was provided by CIRANDA Innovative Organic Ingredients (Hudson, WI, USA). 
RS-2 (70% high amylose corn starch) was from Cargill, Inc. (Cedar Rapids, IA, USA). β-glucan 
from oats was extracted and purified as described (30), except the β-glucan was precipitated by 
adding 3 parts ethanol (by volume) rather than ammonium sulfate. AX was extracted as described 
(59), except arabinoxylan was bleached with hydrogen peroxide after centrifuging and removing 
solids rather than before.  
2.3.3. In vitro digestion of resistant starch 
Because the RS-2 preparation contained some digestible starch, this sample was 
subjected to in vitro digestion prior to fermentation. The digestion process consisted of a 
simulated gastric digestion followed by a small intestinal phase following Mishra and Monro (50) 
with some modifications. RS-2 (25 g) was boiled for 20 min with 300 ml distilled water in a 500 
ml beaker inside of another larger beaker that was filled with boiling water. After cooling to room 
temperature, ~8 ml of 1M HCl were added to the sample to reduce the pH to 2.5. Ten ml of 10% 
(w/v) pepsin (P-700, Sigma, St. Louis, MO USA), dissolved in 0.05M HCl, was added and the 
mixture placed on an orbital shaker (150 rpm) at 37 ℃ for 30 min to achieve the gastric phase. 
The small intestinal phase was initiated with the addition of 50 ml 0.1 M sodium maleate buffer 
(pH=6, containing 1 mM CaCl2) and ~20 ml of 1 M NaHCO3 to bring the pH to 6.9. Fifty ml of 
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12.5% (w/v) pancreatin (P-7545, Sigma), dissolved in sodium maleate buffer, and 2 ml of 
amyloglucosidase (3260 U/ml; Magazyme) were then added and samples were incubated in a 
shaking water bath at 37 °C for 6 h. Digested contents were then poured into dialysis tubing 
(molecular weight cut off 12,000-14,000) and dialyzed for 3 d against distilled water with 
changing of the water every 12 h. The retentate was then frozen (-20 ℃) overnight and then 
freeze dried. The freeze dried, dialyzed material after digestion was analyzed for total starch and 
carbohydrate as described below. 
2.3.4. In vitro fermentation 
Dietary fiber samples and RS-2 after in vitro digestion containing 40 mg of total 
carbohydrate (sum of neutral sugar and uronic acid residues) were suspended in sterile nutrient 
basal medium (64) to a final concentration of 1% (w/v) and then hydrated overnight at 4 °C. 
Fecal samples were then taken from the freezer and defrosted in an anaerobic hood (Bactron IV, 
Sheldon manufacturing, Cornelius, OR USA) containing 5% H2, 5% CO2, and 90% N2. Defrosted 
samples were weighed and mixed with sterile phosphate buffered saline at 10 % (w/v) (64); 
blended for 30 s using a kitchen blender (2774 heritage series, Sunbeam Company, Boca Raton, 
FL USA ), and then filtered through 4 layers of cheesecloth. Tubes were then inoculated with 0.4 
ml of fecal slurry, capped, placed at a 45° angle, and incubated at 37 °C with shaking (140 rpm). 
A sample containing only basal medium and fecal suspension was included as a control and a 
portion of fecal slurry was retained for a zero time reading. Samples were taken at 12 h by 
plunging in an ice bath and then freezing (-80 °C) until analysis. Prior to taking samples, the 
volume of gas produced by the bacteria was measured by inserting a lubricated glass syringe with 
needle through a septum in the cap of the tube. 
2.3.5. Total starch and total carbohydrate assay 
Total starch of RS-2 after in vitro digestion was performed using a kit (K-TSTA, 
Megazyme, Bray, Ireland) to check whether starch was digested during the in vitro digestion 
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process. Total carbohydrate as neural sugars plus uronic acids was determined in all the dietary 
fiber samples except inulin according to AACC International method 32-25 (29) with some 
modifications: 1) the sample size was decreased by half and regents used were decreased 
proportionally, 2) five μL of 2-octanol was added before the reduction step to minimize loss of 
ammonium hydroxide (Englyst and Cummings 1984), and 3) reduction time was increased to 1.5 
h.. Inulin could not be determined in this way, since a significant portion of the fructose was 
degraded during acid hydrolysis. Thus, inulin content was measured using an enzymatic fructan 
kit (K-FRUC, Megazyme, Bray, Ireland). For β-glucan, a mixed-linkage β-glucan kit (K-BGLU, 
Megazyme, Bray, Ireland) was used for quantification of β-glucan specifically (total neutral 
sugars and uronic acids were also quantified in this sample).  
Dietary fiber utilization was determined by analyzing total neutral sugars and uronic 
acids, or content of inulin and β-glucan as described above, after in vitro fermentation on 
collected fecal slurries and subtracting from the content at the beginning of fermentation. 
2.3.6. Short chain fatty acid assay 
 SCFA were analyzed based on Campbell et al. (8). One ml of sample was taken from -
80 °C freezer and thawed at room temperature. Metaphosphoric acid (0.25 ml 5%, w/v) 
containing 5-10 mM 4-methylvaleric acid (A15405, Alfa Aesar, MA, USA) was added into the 
sample tube as an internal standard. Then the tubes were vortex mixed and centrifuged for 20 min 
at 16,000 rpm. Four μL were then injected onto a gas chromatograph (Clarus 580, PerkinElmer, 
Waltham, MA USA) and SCFA were separated on a capillary column (Elite-FFAP, 15 m × 0.25 
mm inner diameter × 0.25 μm film thickness, PerkinElmer) and detected with a flame ionization 
detector. Quantification was accomplished by calculating response factors for each SCFA relative 
to 4-methylvarleric acid using injections of pure standards. 
2.3.7. Composition analysis of the fecal microbiota by pyrosequencing 
2.3.7.1. DNA extraction 
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Fermentation slurries (1 ml) were thawed and the cells were recovered by centrifugation 
(10,000g for 5 min at room temperature). The pellet was resuspended in 0.6 ml stool lysis buffer 
(Buffer ASL, QIAGEN, Maryland, USA) and transferred to a tube containing 300 mg of 
zirconium beads (0.1 mm. BioSpec Products). DNA extraction and purification were then 
processed by the University of Nebraksa-Lincoln’s Core for Applied Genomics and Ecology 
(CAGE) with a Qiagen BioSprint 96 using the BioSprint 96 One-For–All Vet kit and Protocol 
(Purification of Viral Nucleic Acids and Bacterial DNA from Animal Tissue Homogenates, Swab 
Media, and Cell-Free Body Fluids). 
2.3.7.2. Pyrosequencing and data analysis 
Sequencing was performed by CAGE. The V1-V3 region of the 16S rRNA gene was 
amplified by PCR from DNA using primers adapted for the Roche-454 Titanium kit. A mixture 
(4:1) of the primers B-8FM (5’-
CCTATCCCCTGTGTGCCTTGGCAGTCTCAGAGAGTTTGATCMTGGCTCAG-3’) and B-
8FMBifido (5’-
CCTATCCCCTGTGTGCCTTGGCAGTCTCAGAGGGTTCGATTCTGGCTCAG-3’), were 
used as the forward primers. The primer A-518R (5’-
CCATCTCATCCCTGCGTGTCTCCGACTCAGBBBBBBBBATTACCGCGGCTGCTGG-3’) 
containing an 8-base barcode sequence (represented by Bs) was used as the reverse primer. The 
B-8FMBifido primer was used to account for the mismatches that bacteria of the 
genus Bifidobacterium have to the 8FM primer and avoid underrepresentation of this taxa. Equal 
amounts of the PCR products were combined and gel purified. Sequencing was performed from 
the A end primer with the 454/Roche A sequencing primer kit using a Roche Genome Sequencer 
GS-FLX following manufacturer’s protocol for the Roche 454 GS FLX Titanium.  
2.3.7.3. Pyrosequencing data processing pipelines 
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Sequencing process and analysis were based on the combination of QIIME (11) and 
Ribosomal Database Project (RDP) (13) pipelines. Sequences were then assigned to their 
respective samples via the barcode. Quality control of the sequences was performed with QIIME 
to remove sequences with the following attributes: 1) sequences longer than 550 bp or shorter 
than 300 bp; 2) sequences with one or more ambiguous nucleotides; 3) sequences with average 
quality score below 25 4) reads containing homopolymer runs larger than 6 bp; and 5) sequences 
with more than one mismatch to the primer or barcode. Bacterial 16S rRNA sequences were 
classified from the phylum to the genus levels using the Classifier tool (RDP). Local Blasts were 
performed using the standalone ncbi-blastn 2.2.25+ tool with 16S rRNA sequences of type strains 
of bacteria identified as core species of the human microbiome or relevant in carbohydrate 
fermentation as the query sequences (56) and a created local database containing the 16S rRNA 
sequences generated in our study.   Operational Taxonomic Unit (OTU) picking with 97% 
similarity cutoff was performed with QIIME using default parameters. These data were used to 
calculate UniFrac beta-diversity distances and generate the corresponding principal component 
analysis (PCA) plots with QIIME.  
2.4. Statistical analysis 
Differences among dietary fiber treatments and UniFrac index were computed using one-
way ANOVA in combination with Tukey’s post-hoc tests using SAS software (version 9.2, SAS 
Institute, Cary, NC USA). Pearson’s coefficients were computed for correlation analysis. Average 
carbohydrate utilization was determined using ANOVA followed by Fisher’s protected least 
significant difference. T-test was performed to compare the difference in bacterial taxa in fecal 
samples and samples obtained after in vitro fermentation between obese and normal weight 
individuals on each dietary fiber. P<0.05 was used to consider statistical significance. Data were 
expressed as mean±standard error. 
2.5. Results and discussion 
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2.5.1. Characteristics of dietary fiber used for in vitro fermentation 
  Carbohydrate compositions of the dietary fibers used in this study are shown in Table 2.2. 
Dietary fiber does not refer to a single compound, instead, contains a broad class of compounds 
with different chemical structures. Commercial pectin is a linear chain of 1, 4-linked α-D-
galacturonic acid containing varying degrees of methylation (51). Guar gum is a polysaccharide 
composed of galactose residues 1,6- linked to a β-D-mannosyl backbone. The inulin used in our 
study was from agave, with an average DP of 14 (58). The alkali-solubilized AX used in this 
study consisted of a backbone of 1, 4-linked β-D-xylopryanosyl residues, substituted with 
oligosaccharide branches containing arabinose, galactose, glucuronic acid, and xylose (59). β-
Glucan is composed of β-D-glucosyl units linked by 1, 3 and 1, 4 glycosidic bonds. RS-2 
represents starch that is resistant to digestion of human small intestinal enzymes (61).  
 Prior to the in vitro fermentation process with human fecal microbiota, in vitro digestion, 
which imitated the digestion occurring in human gastrointestinal tract, was performed to remove 
digestible starch from the RS-2 preparation (about 20%; Table 2.2). Other purified dietary fibers 
were directly subjected to in vitro fermentation. The β-glucan content measured using an 
enzymatic colorimetric kit was slightly higher than the total glucan content using gas 
chromatography; these differences may due to the differences in methodology. 
2.5.2. Bacterial taxa that were affected by dietary fiber treatments   
Compared with in vivo studies, there are limitations to the in vitro experimental approach. 
In vitro fermentation does not exactly replicate the conditions that occur in the large intestine, 
resulting in blooming or diminishing of certain bacteria taxa. Nevertheless, this methodology is 
correlated well with dietary fiber fermentation in vivo and can provide insight into the 
fermentation profile of different carbohydrates (2). In an effort to separate the shifts in the gut 
microbiota profile resulting from the in vitro environment and the shifts brought on by the dietary 
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fiber treatment, a blank containing no carbohydrate substrate was included alongside the 
fermentations.  
Weighted UniFrac indeces were used to construct PCA graphs comparing each dietary 
fiber treatment with the control containing no dietary fiber (Figure 2.1). Pectin and RS-2 led to a 
more dynamic shift in the bacterial community; other substrates resulted in extensive overlapping 
between the bacterial community of control and dietary fiber. Although 38.5% of the variation in 
composition could be explained by dietary fiber treatments, large individual difference in 
bacterial communities resulted in much overlapping in the PCA figures.   
To further evaluate the shift of bacterial community, phylogenetic beta diversity using 
UniFrac was calculated (Figure 2.2), revealing the relative distance of bacterial communities 
between the original fecal samples and the communities after in vitro fermentation. Only RS-2 
showed a significant impact on shifting the bacterial community compared with the control, 
although differences were observed among dietary fiber treatments.  
Table 2.3 shows the shifts in specific bacterial taxa induced by different dietary fiber 
treatments. The most substantial change was in Bifidobacterium, which increased almost 10-fold 
on pectin compared with the control.  Pectin oligosaccharides have been reported to have 
bifidogenic prebiotic properties (28), while research on commercial pectin is limited. Although 
the commercial pectin we used contained some free glucose, this carbohydrate is not known to 
have prebiotic properties and should not have affected the growth of Bifidobacterium (46).   
Bifidobacterium is thought to play an important role in the improvement of health. For instance, 
protection from enteric infection, suppression of pathogenic bacteria by lowing the intestinal pH 
through breaking down carbohydrates, stimulation of immune response, protecting gut barrier and 
so on (38). Also, suppressed Bifidobacterium has been shown to be associated with obesity (49).  
Other substrates did not result in significant changes in Bifidobacterium. This was 
surprising, as inulin is usually considered a bifidogenic carbohydrate, and, although we did see a 
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numeric increase in Bifidobacterium on inulin, it did not reach significance. The DP of the inulin 
used in this study was fairly high compared with other studies and others have shown that the 
bifidogenicity of inulin-type fructans decreases as DP increases (36, 37). Also, others have shown 
that about 30% of the population are “non-responders” with respect to the bifidogenicity of inulin 
(35); perhaps the subjects in our study had a high percentage of “non-responders.” Additionally, 
Subdoligranulum was enhanced in fermentation residues with high inulin utilization (discussed 
below). Subdoligranulum can produce bacteroicins that could have inhibited growth of 
Bifidobacteria.  
Another significant change was in Erysipelotrichaceae, which significantly increased on 
all dietary fiber substrates, especially on β-glucan and inulin. Higher proportion of 
Erysipelotrichaceae was found with mice fed a high fat diet (21), while other studies indicated 
that four different lineages of this family respond differentially to high fat diets (78). Few studies 
have evaluated the association between this family and carbohydrate consumption (70).  
On the order level, a reduction of Clostridiales was detected on all dietary fibers 
substrates, although this was only significant on RS-2 and pectin substrates. Propensity to high-
fat induced obesity and gut inflammation has been linked to high proportions of this bacterial 
group (17). Furthermore, compared with the control, Ruminococcus was significantly higher on 
all substrates expect RS-2 and pectin. Ruminococcus has also been reported to favor weight loss 
in one study (62). This suggests dietary fibers may inhibit diet induced obesity by inducing a 
reduction in Clostridiales and increasing Ruminococcus.  
All dietary treatments increased the proportion of Actinobacteria, though only pectin 
treatment reached significance.  Among different dietary fibers, the increase in Bacteroidetes was 
significantly higher on AX than other treatments. Dorea was reduced on pectin and inulin 
substrates. Martínez et al (47) also reported a significant decrease of this genus upon resistant 
starch consumption in vivo. A 10-fold increase in Collinsella was detected on inulin substrate, a 
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genus that has been found less abundant in irritable bowel syndrome patients than in healthy 
subjects (34).  
2.5.3. Associations between the gut microbiota and metabolites (SCFA and BCFA) 
 Major bacterial metabolites, SCFA and BCFA, were correlated with all bacterial taxa 
(Table 2.4). Blautia and Bifidobacterium showed a positive correlation with total SCFA 
production, while Proteobacteria, Gammaproteobacteria, Enterobacteriales, and Eggerthella 
displayed a negative relationship. Although SCFA can increase the energy harvest from dietary 
fiber, it only accounts for about 10% total energy harvest from food in humans (48). Furthermore, 
SCFAs contribute several beneficial effects on gut health, including nourishment of the colonic 
mucosa, pathogen resistance and inhibition of cholesterol synthesis (25). Furthermore, they play a 
role in regulation of hormones on energy metabolism. For instance, activation of GPR41 leads to 
up regulation of leptin and peptide YY, two impotent hormones that reduce the appetite (7, 33, 39, 
52, 55). 
The proportion of one phylum, Bacteroidetes, exhibited strong positive correlation with 
both the amount of propionate and propionate proportion. A similar correlation was observed in 
Bacteroidia (class), Bacteroidales (order) and Bacteroides (genus), indicating that Bacteroides 
(genus) had an impact on the propionate production. This finding is in accordance with previous 
research that Bacteroides are propionate producers through the succinate pathway (45). 
Propionate that is absorbed through the intestinal wall primarily acts as a precursor for 
gluconeogenesis, although some animal studies have suggested that it can help reduce hepatic 
cholesterol synthesis (12, 75). In addition, propionate has also been shown to decrease glucose-
induced insulin secretion in isolated pancreatic islet cells of rats (76).  
Butyrate was moderately correlated with the proportion of Firmicutes, Clostridia, 
Incertae Sedis XIV, Blautia and Eubacterium, while Ruminococcaceae and Faecalibacterium 
displayed a robust positive correlation with butyrate production. Ruminococcaceae, a member of 
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Clostridia, is one of the primary butyrate-producing bacteria found in human feces (45). Benus et 
al. (4) showed strong positive correlation between the numbers of Faecalibacterium and the 
production of butyrate. The preferred energy source of coloncytes, butyrate plays an important 
role in the control of the machinery regulation apoptosis and cellular proliferation, resulting in 
lowering the risk of colon cancer (9). Butyrate has also been proposed to ameliorate mucosal 
inflammation (9). Faecalibacterium prausnitzii has been identified as an anti-inflammatory 
commensal bacterium (68), which may be a result of butyrate production from this genus. 
Because SCFAs are produced as a result of carbohydrate fermentation and BCFAs 
represent a good marker of undesirable protein fermentation, SCFA/BCFA could function as an 
indicator of the propensity of the gut microbiota toward carbohydrate fermentation or protein 
fermentation. Although no detrimental impacts have been proposed by BCFA, the presence of 
them are often accompanied with production of toxic metabolites such as ammonia (5, 60). 
Ruminococcaceae indicated a stronger positive association with SCFA to BCFA ratio. Thus 
Ruminococcaceae may either compete with some bacterial taxa that fermented protein or increase 
the fermentation of carbohydrates, thereby reducing fermentation of protein and production of 
BCFA. 
2.5.4. Associations between the gut microbiota and carbohydrate utilization 
 In an effort to deepen our understanding of how dietary fibers are utilized by gut 
microbial communities, we assessed associations between the gut microbiota and carbohydrate 
utilization (Figure 2.3). The gut microbiota were most efficient in using pectin. Notably, the gut 
microbiota were more efficient at utilizing linear carbohydrate polymers [pectin, inulin, β-glucan, 
resistant starch (amylose)] compared with those with side chains (AX, guar gum). Branched 
regions in AX and guar gum may provide resistance to hydrolysis by bacterial enzymes, thus 
influencing the efficiency for bacterial usage. 
58 
 
 
 
 
Fermentation of dietary fibers may select for certain bacteria that are especially equipped 
to utilize that particular polymer (77).  Thus, we correlated the carbohydrate utilization during 
fermentation with all the bacterial taxa (Table 2.5). Bifidobacterium was positively associated 
with the utilization of RS-2. Certain Bifidobacterium are amylolytic and efficient at utilizing 
starch after adhering to the starch granule (16, 57). A strong positive relationship was shown 
between β-glucan consumption and the proportion of Firmicutes. Firmicutes phylum accounts for 
up to 90% total bacteria in our gut, containing members of clostridial cluster IV, XIVa, and other 
groups with different functionality. Although few studies have been conducted to understand the 
mechanism by which bacteria in this phylum use dietary fibers substrates, R. flavefaciens, 
belonging to Firmicutes, possesses the ability to produce a wide range of enzymes, such as 
glycoside hydrolases (endo-1,4-β-glucanase), polysaccharide lyases and carbohydrate esterases 
that can be used to metabolize various dietary fiber polymers (32, 54).  
Our analyses also revealed a robust negative relationship between the inulin utilization 
and Subdoligranulum. Subdoligranulum is phylogenetically a member of Clostridium leptum (27), 
and produces bacteriocins, which are protein toxins that suppress the growth of similar or closely 
related bacterial strains (20). Bacteriocins produced by this genus may have played a role in 
suppressing Bifidobacteria growth during inulin fermentation and explain the lack of a significant 
increase in this genus. 
2.5.5. Dietary fiber, gut microbiota and obesity 
 Obesity is a major health concern in the US. Thus, we desired to determine differences in 
fecal samples and fermentation profiles on different dietary fibers among the fecal samples in our 
study. 
2.5.5.1. Fecal gut microbiota composition from obese and normal weight individuals 
     As mentioned, the gut microbiota in obese individuals is likely different from normal 
weight individuals (15, 22, 43, 65, 79), although results are not conclusive. Thus, three million 
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quality-controlled, chimera-free 16S rRNA gene tags per sample were used to build the 
taxonomic profile of the microbial communities in fecal samples collected and the values were 
expressed as percent taxa abundance to the total number of sequences. At the phylum level, the 
microbiota in both groups were dominated by Firmicutes, Bacteroidetes, Proteobacteria, 
Actinobacteria, and Verrucomicrobia (Table 2.6), which is similar to previous reports (24, 26). 
No significant differences were detected between obese and normal weight groups, in accordance 
with Duncan et al (18). A non-significant trend toward a reduction in Firmicutes and more 
Bacteroidetes and Actinobacteria in obese compared with normal weight was noted. Perhaps with 
more individuals the results would have been significant in accordance with Ley et al (42), who 
reported that obese individuals display a reduced Bacteroidetes to Firmicutes ratio compared with 
lean individuals. Zhang and Schwiertz et al, (65, 79) on the other hand, reported more 
Bacteroidetes in obese individuals. Given that individuals harbor gut microbial communities 
whose relative proportions of predominant microbial groups are tremendously varied (3), and 
Firmicutes and Bacteroidetes contain over 250 genera with different properties (14), it is not 
surprising that our results and those found in the literature are so varied.  
At the family level, Incertae Sedis XIV were approximately three-fold lower in the obese 
group compared with the normal weight group. Reduced Incertae Sedis XIV has been reported in 
patients with pouchitis, a type of inflammatory bowel disease (69), though the relationship with 
obesity remains unknown. Lachnospiraceae, a butyrate producer, were lower in the obese group 
compared with the normal weight group. It has been reported that Lachnospiraceae was less 
abundant in colon cancer patients (73), which may be explained by the beneficial effects of 
butyrate.  
At the genus level, Ruminococcus were significantly reduced in the obese group 
compared with the normal weight group. R. flavefaciens, a subgroup of Ruminococcus, has been 
observed abundant in normal individuals compared with obese (65). In addition, R. bromii are 
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one of the major starch degraders in the colon, producing acetate, butyrate and propionate, which 
has been linked to some health benefits (31, 74). 
2.5.5.2. Difference between obese and normal weight group after in vitro fermentation within 
each dietary fiber 
We compared the abundance of each bacterial taxa within the gut microbiota community 
after in vitro fermentation between the obese and normal weight groups within each dietary fiber 
(Table 2.7). We found that the obese and normal microbiota responded in different fashions 
within the dietary fiber, except when RS-2 was used as substrate. For instance, inulin resulted in 
about 9-fold increase of Bacilli in normal weight group compared with the obese group.  The 
different initial composition between obese and normal weight gut microbiota is likely a 
contributing factor to different fermentation responses on the same substrate. Different response 
between obese and normal weight microbiota could also be due to differences in metabolic 
activity.  
2.6. Conclusion 
 Our results showed that RS-2 caused the most dynamic change of the whole microbiota 
community while Bifidobacterium increased almost 10-fold on pectin. Ruminococcaceae and 
Faecalibacterium displayed a robust positive correlation with butyrate production. We also found 
a strong positive relationship was shown between β-glucan consumption and the proportion of 
Firmicutes, while a robust negative relationship between the inulin utilization and 
Subdoligranulum. 
We also found small but significant differences in the gut microbiota between obese and 
normal weight individuals, namely Incertae Sedis XIV (family), Lachnospiraceae (family), and 
Ruminococcus (genus) were reduced in the obese microbiota. These differences resulted in 
slightly different fermentation profiles when exposed to the same dietary fiber. Given the impact 
of the microbiota of health, more research is needed to explore the association of gut microbiota 
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and dietary fiber degrading activities, so as to influence the gut microbiota to the most desirable 
composition for health. 
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Figure 2.1.Fecal bacterial communities clustered using principal coordinate analysis of the UniFrac matrix; control (no dietary fiber during fermentation) is in 
blue and dietary fibers are in yellow; clockwise from top left: pectin, guar gum, inulin, resistant starch type 2, β-glucan, and arabinoxylan. 
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Figure 2.2. Shift in the gut microbiota based on UniFrac metrics comparing initial fecal sample with final microbiota composition after 12 h of in vitro 
fermentation for each dietary fiber treatment and control containing no carbohydrate; n=15; *p<0.05, **p<0.01, ***p<0.0001. 
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Figure 2.3. Average carbohydrate (CHO) utilization (%) of each dietary fiber during in vitro fermentation; error bars show standard error from different fecal 
samples; bars with different letters are significantly different (n=15; p<0.05); AX, arabinoxylan; RS-2, resistant starch type 2. 
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Table 2.1. Fecal sample donor information 
Patient # BMIa Assigned group Age  Gender  Race 
Bowel movements per 
week 
19 18.4 Normal weight 46 Male Caucasian 10 
20 20.7 Normal weight 24 Female Caucasian 6 
3 21.8 Normal weight 32 Female Caucasian 2 
8 22.1 Normal weight 31 Male AAb 17 
14 22.1 Normal weight 51 Female AA 6 
2 24.1 Normal weight 44 Female AA 2 
29 24.1 Normal weight 31 Female AA 3 
18 25.1 Overweight 56 Male AA 15 
7 25.3 Overweight 56 Female AA 9 
10 26.1 Overweight 23 Male AA 7 
9 31.4 Obese 54 Male AA 3 
15 31.7 Obese 23 Female AA 12 
21 33.2 Obese 51 Female Hispanic 4 
5 36.7 Obese 50 Female AA 7 
4 36.9 Obese 44 Male AA 6 
6 40.1 Obese 52 Male AA 4 
16 40.6 Obese 31 Female Hispanic 4 
17 40.9 Obese 46 Female Caucasian 13 
11 42.8 Obese 29 Female AA 5 
23 45.4 Obese 33 Female AA 6 
aBMI: Body mass index 
bAA: African American 
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Table 2.2. Composition of dietary fibers used for in vitro fermentation. a 
  % dry basis 
Constituent Pectin Guar gum Inulin AXb β-glucan RS-2c 
Arabinose 1.26±0.05 2.03±0.08 NAd 22.73±0.31 1.81±0.02 0.34±0.06 
Xylose 0.18±0.06 0.49±0.01 NA 43.92±0.2 1.98±0.11 0.29±0.03 
Manose 0.32±0.32 46.60±0.89 NA 0.13±0.05 1.09±0.21 0.83±0.002 
Galactose 2.22±0.24 28.22±0.53 NA 6.48±0.14 0.32±0.28 0.35±0.01 
Glucose 38.47±0.86 2.48±0.13 NA 4.66±0.24 73.92±0.04 59.21±0.43 
Uronic acid 35.41±0.22 NA NA 4.21±0.02 NDe ND 
Inulin NA NA 88.21±0.00 NA NA NA 
β-glucan NA NA NA NA 76.64±0.05 NA 
a Mean values ± SE; n=2. Neutral sugars and uronic acids expressed as they would occur in a polysaccharide (0.9*weight of hexose or 0.88*weight of pentose); 
bAX: Arabinoxylan;  RS-2: Resistant starch type 2. Starch digested during in vitro digestion process was 19.80±0.31%. Prior to in vitro digestion, RS2 contained 
80.20±0.31% starch; dNA = not analyzed; eND = not detected. 
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Table 2.3. Abundance of bacterial taxa that were affected by dietary fiber treatments.a,b 
 Control Pectin Guar gum Inulin AX β-glucan RS-2 
Phylum               
Actinobacteria 4.99±1.75b 39.03±7.84a 5.07±1.24b 20.63±5.11b 4.99±1.54b 6.29±1.56b 15.61±5.15b 
Bacteroidetes 8.57±2.01abc 0.87±0.23c 12.43±2.86ab 1.72±0.53c 16.24±3.24a 5.19±1.60bc 5.90±1.90bc 
Class/subclass       
Actinobacteria 4.99±1.75b 39.03±7.84a 5.07±1.24b 20.63±5.11b 6.29±1.56b 4.28±1.54b 15.61±5.15b 
Bacteroidia 8.56±2.01ab 0.87±0.22c 12.41±2.85ab 1.71±0.53c 16.23±3.64a 5.18±1.60bc 5.90±1.90bc 
Actinobacteridae 3.004±0.96b 29.94±7.94a 3.56±0.97b 9.72±3.03b 5.03±1.45b 1.35±0.36b 10.56±4.72b 
Coriobacteridae 1.98±1.03b 9.03±2.86ab 1.49±0.57b 10.88±3.82a 1.25±0.48b 2.93±1.32ab 5.01±2.25ab 
Order/suborder       
Bacteroidales 8.56±2.01abc 0.87±0.22c 12.42±2.85ab 1.71±0.53c 16.23±3.64a 5.18±1.60bc 5.90±1.89bc 
Bifidobacteriales 2.9±0.95b 29.91±7.94a 3.58±0.97b 9.70±3.04b 5.02±1.50b 1.34±0.36b 10.54±4.72b 
Clostridiales 44.62±4.83a 19.46±4.31b 42.08±4.96a 33.99±7.73ab 42.84±5.30a 40.06±4.64ab 20.61±3.56b 
Coriobacteriales 1.98±1.03ab 9.03±2.87ab 1.49±0.57b 10.88±3.38a 1.25±0.48b 2.93±1.32ab 5.01±2.25ab 
Erysipelotrichales 2.28±0.82b 7.22±3.13ab 6.49±1.74ab 19.60±6.46a 3.52±0.88b 20.73±4.59a 6.58±1.75ab 
Actinomycineae 0.01±0.003a 0.001±0.001b 0.001±0.001ab 0.001±0.001b 0.001±0.001b NDb 0.005±0.005ab 
Coriobacterineae 1.98±1.03ab 9.03±2.87ab 1.49±0.57b 10.88±0.38a 1.25±0.48b 2.93±1.32ab 5.01±2.25ab 
Family        
Actinomycetaceae 0.01±0.003a 0.001±0.001b 0.001±0.001ab 0.001±0.001b 0.001±0.001b NDb 0.005±0.004ab 
Bacteroidaceae 7.00±1.86abc 0.69±0.19c 11.04±2.74ab 1.36±0.48c 15.33±3.65a 4.58±1.45bc 5.35±1.85bc 
Bifidobacteriaceae 2.96±0.95b 29.91±7.94a 3.55±0.97b 9.70±3.03b 5.02±1.44b 1.34±0.35b 10.54±4.72b 
Coriobacteriaceae 1.98±1.03ab 9.03±2.87ab 1.49±0.57b 10.88±3.38a 1.25±0.48b 2.93±1.32ab 5.01±2.25ab 
Erysipelotrichaceae 2.28±0.82c 7.22±3.13ab 6.49±1.74ab 19.60±6.46a 3.52±0.88b 20.73±4.59a 6.58±1.79ab 
Incertae Sedis XI 0.057±0.029a NDb 0.008±0.004b NDb 0.004±0.002b 0.013±0.010ab 0.0008±0.0001b 
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Table 2.3 (continued). Abundance of bacterial taxa that were affected by dietary fiber treatments.a,b 
 Control Pectin Guar gum Inulin AX β-glucan RS-2 
Incertae Sedis XIV 2.44±0.44b 3.92±0.97ab 1.93±0.19b 4.73±2.18ab 4.77±0.74ab 10.24±3.77ab 0.90±0.22b 
Porphyromonadaceae 1.43±0.40a 0.13±0.06b 1.01±0.3ab 0.09±0.03b 0.72±0.15ab 0.49±0.19ab 0.43±0.40ab 
Genus        
Anaerostipes 0.024±0.01a NDb 0.009±0.004ab 0.01±0.004ab 0.003±0.002ab 0.006±0.003ab 0.01±0.006ab 
Anaerovorax 0.056±0.028a 0.033±0.018ab 0.009±0.004ab 0.007±0.003ab 0.02±0.005ab 0.006±0.003ab 0.002±0.002b 
Bacteroides 7±1.86abc 0.69±0.19c 11.04±2.74ab 1.36±0.48c 15.33±3.65a 4.58±1.45bc 5.35±1.85bc 
Bifidobacterium 2.88±0.92b 29.26±7.79a 3.88±0.95b 9.49±2.98b 4.94±1.42b 1.31±0.35b 10.30±4.62b 
Blautia 2.43±0.44c 3.9±0.97ab 1.92±0.19c 4.72±2.18ab 4.75±0.74ab 10.23±3.77a 0.90±0.22c 
Butyricicoccus 0.23±0.06ab 0.06±0.03b 0.53±0.16a 0.10±0.04b 0.13±0.032b 0.12±0.045b 0.05±0.03b 
Collinsella 1.72±0.1b 8.88±2.84ab 2.16±0.56b 10.77±3.38a 1.13±0.47b 2.85±1.31ab 4.92±2.24ab 
Coprobacillus 0.94±0.61b 2.28±1.1b 3.73±1.77ab 5.24±3.53ab 1.92±0.63b 12.73±4.30a 2.37±1.29b 
Dorea 8.47±2.49a 0.50±0.13b 4.43±1.10ab 1.01±0.35b 5.03±1.29ab 3.01±1.29ab 4.07±1.39ab 
Eggerthella 0.14±0.038a 0.062±0.003ab 0.042±0.010b 0.035±0.019b 0.033±0.010b 0.033±0.011b 0.038±0.015b 
Holdemania 0.03±0.009a 0.008±0.006ab 0.004±0.002b 0.002±0.001b 0.011±0.005ab 0.001±0.001b 0.002±0.002b 
Parabacteroides 1.42±0.40a 1.13±0.05b 1.0±9.36ab 0.086±0.03b 0.71±0.15ab 0.49±0.19ab 0.43±0.19ab 
Peptoniphilus 0.02±0.013a NDb NDb NDb 0.002±0.001b 0.003±0.002b NDb 
Roseburia 0.18±0.04b 0.17±0.07b 3.16±1.19a 0.44±0.21b 0.83±0.32b 0.99±0.43ab 0.95±0.50ab 
Others 
       Unclassified Bacteroidales 0.096±0.022abc 0.016±0.006bc 0.11±0.027a 0.022±0.008bc 0.20±0.022ab 0.057±0.017bc 0.062±0.017abc 
unclassified Firmicutes 1.07±0.28ab 0.46±0.21b 1.20±0.46ab 1.32±0.80ab 0.98±0.21ab 3.40±1.28a 0.52±0.24b 
unclassified Ruminococcaceae 1.02±0.29b 0.66±0.29b 5.84±2.56a 0.44±0.16b 0.56±0.16b 1.4±0.55b 0.24±0.086b 
unclassified Actinobacteria 0.004±0.002b 0.063±0.015a 0.013±0.007b 0.032±0.012ab 0.009±0.004b 0.003±0.002b 0.031±0.017ab 
unclassified Bifidobacteriaceae 0.08±0.027b 0.65±0.16a 0.07±0.02b 0.21±0.06b 0.08±0.027b 0.032±0.01b 0.24±0.11b 
unclassified Incertae Sedis XIII 0.049±0.019a 0.007±0.003b 0.007±0.002b 0.007±0.003b 0.011±0.005b 0.007±0.004b 0.016±0.007b 
aValues are reported as mean  ± SE (n=15); means in the same row followed by the same letter are not significantly different (p<0.05); bBacterial taxa that did not 
have any statistical significance between different dietary treatments were removed. 
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Table 2.4. Correlation between bacterial metabolites and bacterial populations.a b 
  Total SCFA Butyrate Propionate Butyrate/SCFA Propionate/SCFA SCFA/BCFA
c 
Phylum  
    
 
Acidobacteria 
    
0.23* 
Actinobacteria 0.24* 
   
-0.37** 
 Bacteroidetes 
 
0.58** 
 
0.59** 0.27* 
Firmicutes 0.29** 0.31** 
   Fusobacteria 
   
0.42** 
 Proteobacteria -0.25* -0.33** -0.27** 
 
0.23** 
 Verrucomicrobia 
    
0.22* 
Class/subclass      
Actinobacteria 
 
-0.23* 
 
-0.37** 
 Bacteroidia 
 
0.58** 
 
0.59** 0.27** 
Clostridia 
 
0.24* 
    Gammaproteobacteria -0.25* -0.32** 
 
-0.28** 0.22* 
 Actinobacteridae 0.32** 
   
-0.31** 
 Coriobacteridae 
 
-0.21* 
 
-0.25* 
 Peptococcaceae  
   
0.26* 0.2* 
Actinomycineae -0.28** 
     Coriobacterineae 
   
-0.25* 
 Order  
    
 
Actinomycetales -0.26** 
     Aeromonadales 
   
0.3** 
 Bacteroidales 
 
0.59** 
 
0.59** -0.27** 
Bifidobacteriales 0.32 
   
-0.31** 
 Clostridiales 0.24* 
    Coriobacteriales 
 
-0.21* 
 
-0.25* 
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Table 2.4 (continued). Correlation between bacterial metabolites and bacterial populations.a b 
Total SCFA Butyrate Propionate Butyrate/SCFA Propionate/SCFA SCFA/BCFAc 
Enterobacteriales                                -0.25* -0.32**    -0.28** 0.22*  
Fusobacteriales    0.42**  
Lactobacillales     -0.21* 
Verrucomicrobiales 
    
-0.22* 
Family   
 
  
 Bacteroidaceae 
 
0.53** 
 
0.54** 0.28** 
Bifidobacteriaceae 0.32** 
   
-0.31** 
 Coriobacteriaceae 
 
-0.21* 
 
-0.25* 
 Enterobacteriaceae -0.25* -0.32** 
 
-0.28** 0.22* 
 Eubacteriaceae 
  
0.22* 
  Incertae Sedis XI 0.21* 
     Incertae Sedis XIV 0.4** 0.36** 
 
0.21* 
 
0.34** 
Peptostreptococcaceae 
   
-0.3* 
Porphyromonadaceae 0.46** 
 
0.51** 
 Ruminococcaceae 0.29** 0.48** 0.24* 0.39** 
 
0.4** 
Streptococcaceae 
    
-0.2* 
Veillonellaceae 0.3** 0.22* 0.6** 
 
0.46** 
 Genus    
 
 
 Actinomyces -0.26** 
    
0.21* 
Akkermansia 
    
-0.22* 
Alistipes 
    
0.22* 
 Anaerovorax 
    
-0.2* 
Asticcacaulis 
 
0.23* 
 
0.2* 
 Atopobium 
     Bacteroides 
 
0.52** 
 
0.54** 
 Bifidobacterium 0.32** 
   
-0.31** 
 Blautia 0.4** 0.36** 
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Table 2.4 (continued). Correlation between bacterial metabolites and bacterial populations.a b 
Total SCFA Butyrate Propionate Butyrate/SCFA Propionate/SCFA SCFA/BCFAc 
Citrobacter      
Clostridium   0.2* 0.2*  
Collinsella  -0.21*  -0.25*  
Coprococcus  0.47**  0.52**  
Eggerthella                                         -0.45**      
Enterobacter 
    
0.32** 
Escherichia/Shigella -0.25 -0.33** 
 
-0.28** 0.23** 
 Eubacterium  0.23* 
 
0.22* 
  Faecalibacterium 0.36**   0.63** 
 
0.54** 
 
0.41** 
Gordonibacter -0.31** 
     Gp25 
     
0.23* 
Klebsiella 
    
0.38** 
Lactococcus -0.3 
     Megasphaera 
 
0.23* 
   Mitsuokella 
     Mogibacterium 
   
0.27** 
 Odoribacter 
     Olsenella 
    
0.34** 
 Oscillibacter 
 
0.35** 
 
0.28** 
 Oxalobacter 
     Paenibacillus 
     Parabacteroides 
 
0.46** 
 
0.51** 
 Paraprevotella 
    
0.22* 
Parascardovia 
     Parasporobacterium 
    Parasutterella 
     Peptococcus 
   
0.22* 0.23* 
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Table 2.4 (continued). Correlation between bacterial metabolites and bacterial populations.a b 
 Total SCFA Butyrate Propionate Butyrate/SCFA Propionate/SCFA SCFA/BCFAc 
Phascolarctobacterium       
Phascolarctobacterium 0.29* 0.22* 0.59** 
 
0.4** 0.29* 
Prevotella 
 
0.22* 
   Robinsoniella -0.2* 
     Roseburia 0.24* 
     Samsonia   0.3*  0.2*  
Sarcina 
  
0.24* 
   Slackia 0.29** 
 
0.23* 
   Sporacetigenium 
    
-0.29** 
Staphylococcus 
     Streptococcus 
    
-0.2* 
Subdoligranulum -0.29** -0.22* -0.2* 
   Succinivibrio 
   
0.3** 
 TM7_genera_incertae_sedis 
    Tsukamurella 
     Turicibacter 
    
-0.2* 
Others  
   
 
 unclassified_"Bacteroidales" 0.7** 
 
0.77** 0.25* 
unclassified_"Bacteroidetes" 0.37** 
  
0.21* 
unclassified_"Fusobacteriaceae" 
 
0.42** 
 unclassified_"Fusobacteriales" 
 
0.31** 
 unclassified_"Porphyromonadaceae" 0.21* 
 
0.26* 
 unclassified_"Prevotellaceae" 0.19* 
   unclassified_Actinobacteria 0.35** 
   
-0.33** 
 unclassified_Actinobacteridae 
    unclassified_Actinomycetaceae 
 
0.31** 
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Table 2.4 (continued). Correlation between bacterial metabolites and bacterial populations.a b 
 Total SCFA Butyrate Propionate Butyrate/SCFA Propionate/SCFA SCFA/BCFAc 
unclassified_Betaproteobacteria 0.59* 
 
0.33** 
 unclassified_Bifidobacteriaceae 0.33* 
     unclassified_Enterobacteriaceae 
 
0.29** 
 unclassified_Incertae Sedis XIV 0.25* 
    unclassified_Veillonellaceae 0.29**   0.52**   
aOnly significant correlations are presented; * significance at p < 0.05; **significance at p < 0.01; correlation coefficients greater than 
|r| = 0.45 are bold-printed; bBacterial taxa where the sum of population in all 15 subjects <1% were excluded; cSCFA: Short chain fatty 
acid; BCFA: branched chain fatty acid. 
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Table 2.5.Correlation between carbohydrate utilization and bacteria population. a b 
   
Uronic acid 
in pectin Guar gum Inulin AX β-glucan RS-2 
Phylum        
Actinobacteria  
     
0.66* 
Proteobacteria  
 
-0.52* 
  
-0.64** -0.66* 
Firmicutes  
    
0.73** 
 Class/subclass        
Actinobacteria  
     
0.66* 
Gammaproteobacteria  
 
-0.53* 
  
-0.64** -0.62* 
Erysipelotrichi  
    
0.69** 
 Actinobacteridae  
     
0.56* 
Order        
Erysipelotrichales  
    
0.69** 
 Enterobacteriales  
 
-0.53* 
   
-0.62* 
Bifidobacteriales       0.56* 
Family        
Eubacteriaceae  -0.73** 
     Bacteroidaceae  
      Enterobacteriaceae  
 
-0.53* 
  
-0.64** -0.62* 
Bifidobacteriaceae  
     
0.56* 
Erysipelotrichaceae  
    
0.69** 
 Lactobacillaceae  
 
-0.58* 
    Genus        
Bifidobacterium  
     
0.56* 
Subdoligranulum  
  
-0.73** 
   Escherichia/Shigella  
 
-0.55* 
  
-0.64** -0.63* 
Coprobacillus  
    
  0.54* 
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Table 2.6.Correlation between carbohydrate utilization and bacteria population. a b 
      
                                        Uronic acid  
                                         in pectin Guar gum Inulin AX β-glucan RS-2 
Eubacterium                    -0.74**        
Others      
unclassified_"Bacilli"    0.58**  
unclassified_Actinobacteridae  0.56*    
unclassified_Bifidobacteriaceae       0.59* 
a Only significant correlations are presented; * significance at p < 0.05; **significance at p < 0.01; correlation coefficients greater 
than |r| = 0.45 are bold-printed; bBacterial taxa where the sum of population in all 15 subjects <1% were excluded; cSCFA: Short 
chain fatty acid; BCFA: branched chain fatty acid. 
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Table 2.7. Differences in the fecal microbiota obtained from normal weight (n=7) 
and obese (n=8) individuals a,b 
    Normal  weight Obese P-value 
Phylum     
Firmicutes 81.8±4.16 74.99±4.82 0.31 
Bacteroidetes  6.67±3.15 9.57±3.90 0.58 
Proteobacteria 4.16±3.68 3.28±1.59 0.82 
Actinobacteria 4.35±1.01 9.49±3.08 0.16 
Verrucomicrobia 1.69±1.44 1.51±1.42 0.93 
Synergistetes 0.12±0.12 ND c  0.3 
Class 
    Clostridia 
 
78.11±4.21 65.81±3.97 0.053 
Erysipelotrichi 1.98±0.38 6.68±2.31 0.084 
Order/suborder 
   Bifidobacteriales 1.26±0.37 6.27±2.35 0.071 
Clostridiales 77.75±4.23 65.72±3.99 0.059 
Erysipelotrichales 1.98±0.38 6.66±2.31 0.084 
Class/subclass 
   Actinobacteridae 1.28±0.37 6.31±2.35 0.0705 
Family /subfamily  
   Incertae Sedis  XIV 22.02±3.83 7.75±1.43 <0.0001 
Lachnospiraceae 27.05±1.57 18.18±3.30 0.04 
Bifidobacteriaceae 1.26±0.37 6.27±2.35 0.071 
Erysipelotrichaceae 1.98±0.38 6.66±2.31 0.084 
Eubacteriaceae 0.43±0.31 9.02±4.13 0.076 
Clostridiaceae 0.097±0.04 0.018±0.013 0.098 
Genus  
    Blautia (Ruminococcus)d 21.96±3.84 7.70±1.43 <0.0001 
Bifidobacterium 1.22±0.36 6.02±2.28 0.073 
Eubacterium 0.76±0.42 8.99±4.14 0.076 
Others      
unclassified_Bifidobacteriaceae 0.02±0.02 0.24±0.08 0.03 
aValues are presented as percent; mean ± SE (n=7 in normal weight group and n=8 in obese group); bT-test was used 
to compared the different bacterial taxa between obese and normal weight individuals; all differenced among 
bacteria at the phylum level are reported; for other classifications, only bacterial groups where p for difference was 
<0.1 are reported. Significant p-values (<0.05) are in bold; cnot detected; dsome or all members of Ruminococcus 
have been reassigned to Blautia on the basis of 16S rRNA gene sequence.
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Table 2.8. Difference in abundance of bacterial taxa between obese and normal weight group after dietary fiber treatments.a,b 
  Control   Pectin   Guar gum   Inulin   
  Normal Obese Normal Obese Normal Obese Normal Obese 
Phylum 
        Actinobacteria 1.54±0.36 7.14±2.15  30.48±10.31 46.51±11.53 2.99±0.75 6.88±2.08 15.31±8.47 25.28±6.08 
Class/Subclass 
       Bacilli 3.91±0.87 5.28±2.42 18.35±10.95 1.49±0.69 11.15±8.85 1.27±0.36 9.86±4.25 1.05±0.53 
Actinobacteria 1.54±0.36 7.14±2.14 30.49±10.31 46.51±11.53 2.99±0.75 6.88±2.08 15.31±8.47 25.28±6.08 
Actinobacteridae 0.76±0.41 4.40±1.50 22.56±10.15 36.39±12.07 1.72±0.80 5.18±1.50 5.86±2.82 13.09±5 
Order 
        Bifidobacteriales 0.74±0.41 4.34±1.38 22.54±10.14 36.33±12.06 1.70±0.79 5.16±1.49 5.84±2.81 13.07±5 
Family 
        Bifidobacteriaceae 0.74±0.41 4.35±1.37 22.54±10.14 36.35±12.06 1.70±0.79 5.16±1.49 5.84±2.81 13.07±5 
Genus 
        Coprobacillus 0.59±0.2 1.15±1.03 4.58±2.11 0.27±0.13 0.16±0.12 0.04±0.02 10.19±7.34 0.9±0.47 
Anaerotruncus 0.08±0.03 0.09±0.05 0.05±0.02 0.03±0.02 0.06±0.02 0.03±0.02 0.03±0 ND 
Butyricicoccus 0.29±0.11 0.18±0.07 0.08±0.05 0.04±0.02 0.39±0.11 0.66±0.29 0.19±0.08 0.03±0.01 
Catenibacterium 0.25±0.19 1.61±0.94 0.05±0.03 8.85±5.66 1.87±1.57 2.85±1.35 0.69±0.55 25.19±9.96 
Bifidobacterium 0.72±0.40 4.23±1.34 22.10±9.98 35.52±11.83 1.66±0.76 5.07±1.47 5.69±2.74 12.82±4.91 
Unclassified 
       unclassified_"Clostridia" 0.03±0.01 0.03±0.02 0.06±0.02 ND 0.32±0.14 0.01±0.006 0.02±0.008 0.001±0.001 
unclassified_"Bacilli" 0.03±0.01 0.09±0.06 0.05±0.05 0.005±0.005 0.02±0.009 0.03±0.01 0.02±0.007 ND 
unclassified_Bifidobacteriaceae 0.02±0.009 0.12±0.04 0.44±0.18 0.83±0.24 0.05±0.03 0.09±0.03 0.15±0.08 ND 
unclassified_Clostridiales 3.34±0.46 3.08±0.79 0.004±0.004 ND 2.08±0.44 2.84±0.56 0.003±0.003 ND 
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Table 2.7 (continued). Difference in abundance of bacterial taxa between obese and normal weight group after dietary fiber treatments.a,b 
    AX β-glucan RS-2 
    Normal Obese Normal Obese Normal Obese 
Phylum 
       Actinobacteria 2.87±0.7 9.27±2.45 1.4±0.37 6.80±2.62 6.11±2.94 23.92±8.46 
Class/Subclass 
      Bacilli 
 
3.11±1.37 3.39±1.83 13.83±8.66 1.12±0.44 17.63±10.64 1.18±0.72 
Actinobacteria 2.87±0.70 9.28±2.46 1.40±0.37 6.80±2.62 6.11±2.94 23.92±8.46 
Actinobacteridae 1.92±0.65 7.75±2.3 0.58±0.20 2.03±0.56 1.92±1.22 18.13±8.06 
Order 
       Bifidobacteriales 1.91±0.64 7.74±2.30 0.57±0.20 2.02±0.56 1.92±1.22 18.08±8.04 
Family 
       Bifidobacteriaceae 1.91±0.64 7.74±2.30 0.57±0.20 2.02±0.56 1.92±1.22 18.08±8.04 
Genus 
       Coprobacillus 2.23±0.74 1.65±1.02 2.39±1.10 6.49±2.40 3.17±2.42 1.68±1.32 
Anaerotruncus 0.06±0.02 0.05±0.03 20.48±7.71 5.95±3.21 0.26±0.01 0.07±0.05 
Butyricicoccus 0.16±0.05 0.11±0.04 0.03±0.02 0.01±0.007 0.09±0.06 0.10±0.008 
Catenibacterium 0.16±0.09 2.30±1.40 0.09±0.03 0.14±0.08 3.58±2.31 4.37±2.33 
Bifidobacterium 1.90±0.64 7.61±2.26 0.55±0.19 1.97±0.55 1.86±1.18 17.68±7.87 
Unclassified 
      unclassified_"Clostridia" 0.08±0.05 0.18±0.008 0.004±0.002 0.009±0.005 0.19±0.01 ND 
unclassified_"Bacilli" 0.006±0.004 0.24±0.01 0.003±0.002 0.0051±0.003 0.06±0.03* 0.0025±0.001 
unclassified_Bifidobacteriaceae 0.02±0.009 0.13±0.04 0.02±0.01 0.039±0.016 0.05±0.03 0.40±0.18 
unclassified_Clostridiales 3.25±0.84 2.50±0.55 1.88±0.21 4.10±0.90 1.55±0.60 1.89±0.64 
a Values are reported as mean  ± SE (n=7 in normal weight group and n=8 in obese group); b Within each dietary fiber 
treatment, t -test was used to compared the bacteria population. Only taxa that reach statistical significance were reported. 
Numbers in bold represent proportions that were significantly difference between obese and normal group. Significance at p 
< 0.05.  
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CHAPTER 3. IN VITRO FERMENTATON OF DIETARY FIBERS FROM 
SELECTED WHOLE GRAINS USING FECAL MICROBIOTA FROM OBESE AND 
NORMAL WEIGHT INDIVIDUALS 
3.1. Abstract 
Aberrations in the gut microbiota have been associated with obesity and other metabolic 
diseases. One way that gut bacteria may influence metabolism is through their metabolites 
[mainly short chain fatty acids (SCFA)], which can influence hormones involved in energy 
absorption, utilization, and storage. Epidemiological evidence suggests that obese individuals 
generally consume less whole grains than normal weight individuals; thus whole grains may 
improve the metabolic function of the aberrant microbiota in obese individuals and improve 
health. Five whole grains [wheat, rye, maize (corn), rice, and oats] were subjected to in vitro 
digestion and fermentation using fecal samples from eight obese and seven normal weight people 
by leaving fecal samples separate and by combining all fecal samples from each group to make 
normal weight and obese composite microbiota (NCM and OCM, respectively). When fecal 
samples were kept separate, large differences were observed in SCFA and gas production among 
individuals, even within group. When fecal samples from each group were combined, from 0-6 h, 
bacteria in NCM produced more SCFA than the OCM (10.95±1.82 vs. 0.83±0.13 μmol/h/100mg 
carbohydrate, respectively, p <0.0001); whereas during 12-24 h, the OCM produced more SCFA 
than the NCM (12.15±3.19 vs. 7.74±1.41 μmol/h/100mg carbohydrate, respectively, p<0.035). 
Butyrate production from the NCM was significantly higher than from the OCM, while 
propionate production from OCM was significantly higher than NCM. These data confirm that 
there are large differences in fermentation profiles among individuals, even when supplied with 
the same dietary fiber; however, using composite microbiota it was apparent that the OCM was 
less metabolically active than the NCM initially, but that given sufficient whole grain substrates 
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the bacteria quickly bacome metabolically active. The OCM was also less butyrogenic than the 
NCM. 
 
3.2. Introduction 
Globally, 300 million people are obese and more than 100 billion are overweight [1]. 
Obesity is a serious public health concern, since it leads to conditions such as heart disease, stroke, 
type 2 diabetes and certain types of cancer [2]. Therefore, new insight and strategies on 
preventing obesity are becoming increasingly urgent. 
Recently, the association between the gut microbiota and obesity has been a subject of 
intense investigation. The human gut is a complex microbial ecosystem containing about 100 
trillion microorganisms that may play pivotal roles in energy absorption [3], utilization [4], and 
storage [5-7]. There is increasing evidence that the relative proportions of members of the gut 
microbiota are associated with obesity [8, 9]. Changes in the gut microbiota have resulted from 
dietary intervention and weight loss [10, 11]. 
  The gut microbiota survive in large part on dietary fibers that escape digestion in the 
upper gastrointestinal tract. Fermentation of dietary fibers by gut bacteria result in, among other 
products, short chain fatty acids (SCFA). Normal colonic epithelia cells derive 70-90% of their 
energy supply from SCFA, especially butyrate [12]. Fifty to seventy percent of acetate is taken up 
by the liver and becomes a substrate for cholesterol synthesis; propionate is also largely taken up 
by the liver and is incorporated into gluconeogenesis, liponeogenesis and protein synthesis 
pathways [13, 14].  
SCFA contribute to various metabolic processes, accounting for about 10% of total 
energy harvest from food in humans [15]. However, SCFA induce a satiety-enhancing effect 
which has been suggested to offset the increased energy they provide [16, 17]. Furthermore, 
SCFA may play key roles in regulation of hormones involved in energy metabolism. For instance, 
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two G-protein couple receptors, GPR43 and GPR41, can be activated by SCFA [18-20]. 
Activation of GPR41 leads to up-regulation of leptin and peptide YY (PYY), hormones that 
reduce appetite [21, 22]. SCFA may also activate proliferator-activated receptor-α (PPAR-α), a 
transcription factor that is involved in fatty acid, lipoprotein, bile acid and amino acid metabolism. 
Thus one way the gut microbiota may influence energy metabolism is through the production of 
SCFA from carbohydrate fermentation [23]. 
Epidemiological studies have found there is an inverse association between consumption 
of whole grain and obesity [24]. Whole grains are a good source of dietary fiber and many unique 
bioactive phytochemicals that may influence metabolism of microbiota in favor of weight 
reduction. Thus, the purpose of this study was to compare SCFA production from fecal 
microbiota obtained from obese and normal weight individuals upon whole grain fermentation in 
an effort to explain how whole grains may reduce obesity. 
3.3. Materials and Methods 
3.3.1. Whole grains  
Whole grain brown rice (Oryza sativa L.) was obtained from Riceland Foods, Inc. 
(Stuttgart, AR USA). Maize (Zea mays L., referred to herein as “corn”) and hard red winter wheat 
(Triticum aestivum L.) were gifts from Stephen Mason (University of Nebraska-Lincoln) and P. 
Stephen Baenziger (University of Nebraska-Lincoln), respectively. Oat groats (Aveba sativa L.) 
and dark rye flour (Secale cereale L.) with about 10% added bran were provided by ConAgra 
Mills (Omaha, NE USA) and Grain Millers Inc. (Minneapolis, MN USA) respectively. Oats, 
wheat, and brown rice were milled with a cyclone sample mill (UDY, Boulder, CA USA) 
equipped with a 1 mm screen. Corn was milled on a micro hammer mill (Glen Mills, Clifton, NJ 
USA) equipped with a 2 mm screen. Whole grains were analyzed for moisture according to 
AACC International 44-15A method [25], starch (K-TSTA, Megazyme, Bray, Ireland) and total 
dietary fiber (see below). 
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3.3.2. Fecal samples 
  Fifteen selected fecal samples were obtained from Rush University Medical Center as 
described in section 2.3.1.  
3.3.3. In vitro digestion 
  The digestion process consisted of a simulated gastric digestion followed by a small 
intestinal phase following the method as described in section 2.4.1.  
3.3.4. In vitro fermentation 
In vitro fermentation followed two methods (Figure 3.1) based on whether the 
fermentation was performed without combining fecal samples (method 1) or whether the fecal 
samples from normal weight individuals or obese individuals were pooled to produce composite 
microbiota (NCM = normal composite microbiota; OCM = obese composite microbiota; method 
2). Small scale in vitro fermentation was completed as described in section 2.4.2 using 10 mg 
total carbohydrate per tube (method 1) or 40 mg of carbohydrate per tube (method 2) with buffer 
and media volumes increased proportionally. For method 1, samples were taken at 12 h by 
plunging in an ice bath and then freezing (-80 °C) until analysis. For method 2, samples were 
taken at 6, 12, and 24 h of fermentation in a similar manner. Prior to taking samples, the volume 
of gas produced by the bacteria was measured by inserting a lubricated glass syringe with needle 
through a septum in the cap of the tube. 
3.3.5. Total dietary fiber and total carbohydrate 
Total dietary fiber and total carbohydrate were analyzed in whole grain samples before 
and after in vitro digestion, respectively. The dietary fiber content was determined as sum of 
neutral sugar residues, uronic acid residues and Klason lignin; total carbohydrate was the sum of 
neutral sugar and uronic acid residues. Neutral sugars and uronic acids were quantified according 
92 
 
 
 
to the method as described in section 2.3.5. Klason lignin was determined as described by 
Theander and Westerlund [26]. 
3.3.6. Short chain fatty acids 
Short chain fatty acids (SCFA) were quantified following the same protocol as described 
in section 2.3.6.  
3.4. Statistical analysis 
 For method 1, fecal donor served as replication within weight group (obese vs. normal 
weight); 6 tubes were fermented per donor (1 for each whole grain plus the blank containing no 
carbohydrate). For method 2, the fermentation tube itself served as a replicate, which was 
performed in duplicate. Thus, 12 tubes were fermented per composite microbiota (2 for each 
whole grain plus 2 for the blank). The effects of different whole grains on SCFA and gas 
production were determined using analysis of variance (ANOVA) followed by Fisher’s protected 
least significant difference using SAS software (version 9.2, SAS Institute, Cary, NC USA) with 
α=0.05 to indicate a significant difference. Data were expressed as mean±standard error. 
3.5. Results and discussion 
3.5.1. Total carbohydrate content 
The starch content and dietary fiber content of five whole grain starting materials are 
shown in Table 3.2. Before subjecting the whole grain to in vitro fermentation, in vitro digestion 
procedure was performed to mimic the digestion process occurring in the gastrointestinal tract.  
After in vitro digestion, starch content was removed to under 4.5% on all five substrates (Table 
3.2). Considering that the resistant starch content of whole grain is about 3.3% [27], we 
concluded that the in vitro digestion procedure was successful at removing the digestible starch 
[26, 27]. 
3.5.2. Gas production (method 1) 
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No significant differences in gas production were observed between obese and normal 
weight group (Table 3.2). The least gas production was detected from both groups on corn 
substrate. 
3.5.3. SCFA production from individual fecal microbiota (method 1) 
 In vitro fermentation of whole grains resulted in the production of gas and SCFA (Table 
3.2). Minor fermentation occurred in the blank (without substrate) due to fermentation of residual 
substrates in the inoculum. Among the different whole grain substrates, butyrate production was 
significantly higher on rye substrate and propionate production was significantly higher on rice 
substrate compared with other cereal substrates. Unfortunately, no significant differences in 
metabolite production were observed between normal weight individuals compared with obese 
individuals for any of the whole grain samples. The reason for this is evident in Figure 3.2, which 
shows large differences in SCFA production among individuals, even within weight group. This 
supports previous research showing that individuals harbor gut microbial communities whose 
species composition and relative proportions of dominate microbial groups are tremendously 
varied due to host genetic and environmental factors [30].   
 There appeared to be an upward trend in SCFA production with increasing BMI in obese 
group (Figure 3.2); however, correlation coefficients were not significant (all obese data 
combined: p=0.10, for individual whole grain: corn, p=0.23; oats, p=0.37; rice, p=0.78; rye, 
p=0.42; and wheat, p=0.61). Were the trend significant, this would have supported Schwiertz et al. 
[31] who reported higher SCFA concentrations in obese fecal samples compared with normal 
weight fecal samples. Ley et al. [32] also observed higher SCFA in caeca of obese mice 
compared with lean mice.  
In the dietary fiber literature, it is common to pool fecal samples to reduce individual 
variation in fecal microbiota to more clearly gauge differences in fermentation profiles among 
different dietary fiber substrates [33-34]. We hypothesized that combining fecal samples from 
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each group may help decipher differences between obese and normal weight microbiota 
metabolic products by reducing individual variation. When combining the fecal samples, 
although biases arise because of the competition between gut microbiota from different individual 
fecal sources, to some degree it can represent the relative whole picture and characteristics of 
normal or obese type microbiota [35]. This was the reason for performing method 2 (discussed 
below). 
3.5.4. Gas production (method 2) 
For method 2, the gas produced from NCM was significantly higher at all-time points on 
all substrates, except for rice at 6 h (Figure 3.3). Higher gas production in NCM was associated 
with higher metabolic activity, which is in accordance with SCFA data (discussed below) and 
could be regarded as an indication that the bacteria were more metabolically active in the normal 
weight group. On oats and rye substrates more gas was produced from NCM compared with other 
substrates, which could be due to higher soluble dietary fiber content in oats and rye compared 
with other whole grain [36, 37]. Higher β-glucan content in oats has been associated with bloating 
in some cases [38].  Generally, wheat produced less gas in NCM and OCM compared with other 
whole grains which suggest less potential of causing bloating. 
3.5.5. SCFA production from composite fecal microbiota (method 2) 
   When comparing the average SCFA production from NCM and OCM during different 
fermentation periods, significant differences were observed. At the beginning of fermentation (0-
6 h), the rate of SCFA production in the NCM was significantly higher (about 15 times higher) 
than the OCM (Figure 3.4), whereas during the final half of fermentation (12-24 h), the rate of 
SCFA production was significantly higher in the OCM compared with the NCM. Thus, the OCM 
showed a longer lag period than the NCM.  
 These results are at first in opposition to Schwiertz et al. [4] and Ley et al. [31] who 
reported greater SCFA production in the feces (human) and cecum (mice) of obese compared 
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with normal weight individuals, respectively. However, it is possible that these results are in 
accordance with at least Schwiertz et al. [4] when considering that the obese microbiota may 
display protracted fermentation compared with normal weight individuals; thus delaying 
fermentation and resulting in higher fecal SCFA. Reports that obese individuals consistently 
consume less dietary fiber-rich foods than normal-weight individuals in epidemiological studies 
[39] may explain why the OCM were in more of a dormant state during the initial several hours 
of fermentation. Notably, however, the OCM was able to metabolize the whole grain substrates 
after sufficient exposure such that total SCFA production was not significantly different from the 
NCM after 24 h (250.14±49.46 μmol /100mg carbohydrate vs. 259.40±39.47 μmol /100mg 
carbohydrate, respectively, p for difference =0.62).  
 By combining fecal samples from each weight group, significant differences in individual 
SCFA production were evident between NCM and OCM (Table 3.3). After 6 h of fermentation, 
NCM produced more acetate than OCM regardless of whole grain substrate. Surprisingly, no 
propionate or butyrate production from NCM was detected during this stage of fermentation, and 
amounts of butyrate and propionate detected from OCM were not significantly different from 
zero (p>0.05). This may be a result of starting the in vitro cultures with frozen fecal samples; 
some bacteria needed time before becoming metabolically active after being frozen [40]. It is also 
possible that other factors such as pH of the medium may have affected the production of SCFAs. 
The pH of the initial medium was about 7.4; many saccharolytic bacteria thrive better under more 
acidic conditions such as between 5 and 6 [41]. Also, acetate producing bacteria instead of 
butyrate or propionate producing bacteria may have initially competed more successfully for the 
utilization of whole grain substrates [42]. Kaur et al. [43] also reported some negative propionate 
values compared with the controls at 4 and 8 h under in vitro fermentation conditions.  
 After 12 h of fermentation, the NCM continued to produce more acetate than OCM on all 
five whole grain substrates (Table 3.3). OCM produced significantly more propionate compared 
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with NCM on all substrates except rye, whereas butyrate production was not significantly 
different between NCM and OCM except on wheat substrate.   
Also at 12h of fermentation, significantly less propionate production from OCM on all 
whole grains except corn was detected compared with NCM, while after extended fermentation of 
whole grain substrates more propionate was observed from OCM except on corn substrate (Table 
3.3). This is in support of Schwiertz et al. [31], who showed an enrichment in propionate in fecal 
samples from obese individuals compared with normal weight.  
 At the end of the fermentation (24 h), butyrate from NCM was higher than from OCM 
except on corn substrate. This may have been a result of lower pH in the NCM slurries, brought 
about by the decreased pH as a result of rapid acetate production by the NCM at the beginning of 
fermentation, which supported the formation of butyrate by allowing butyrate-producing bacteria 
to compete against those that are less prone to butyrate production [45].  
 Butyrate production was highest when NCM was on oats substrate compared with other 
whole grain (Table 3.4). This is in accordance with the finding of Queenan et al [38] and 
Connolly et al [46] showing that fermentation of oats leads to significant increase in butyrate 
production. 
 Butyrate exhibits many benefits on colon health. It has been reported that 70%-90% of 
butyrate is metabolized by colonocytes [47]. As the preferred energy source of colonocytes, 
butyrate has also been implicated in the control of the machinery regulating apoptosis and cellular 
proliferation and differentiation, therefore decreases the risk of colon cancer. At the intestinal 
level, butyrate plays a regulatory role in the transepithelial fluid transport, ameliorates mucosal 
inflammation and oxidative status, reinforces the epithelial defense barrier, and modulates 
visceral sensitivity and intestinal motility [46]. Butyrate supplementation in obese mice 
significantly reduced obesity and insulin resistance. The underlying mechanism of butyrate action 
may due to stimulation of energy expenditure and induction of mitochondria function [49]. Other 
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research also reported that butyrate may promote satiety through inhibition of nuclear factor-κB 
activation, although human data are still limited [50]. 
3.5.6. BCFA production from composite fecal microbiota (method 2) 
 With regard to BCFA, more production from NCM was detected at the end of the 
fermentation though on some substrates the difference was not significant (Table 3.4). BCFAs 
result from amino acid fermentation. No studies have shown the detrimental effects caused by 
BCFAs themselves, although production of undesirable toxic metabolites and BCFAs often 
couple with each other [29, 51]. The higher BCFAs produced from the NCM may result from the 
induction of higher bacterial metabolism, which was also suggested by the SCFA production data. 
3.5.7 Comparison between method 1 and method 2 
When comparing the results from method 1 and method 2, some contradictory results 
arise. Method 1 suggested (p=0.10) an increasing trend in SCFA production after 12 h of 
fermentation as BMI increased in the obese group. This is in accordance with several reports 
showing greater metabolic activity in obese microbiota compared with normal weight [31,52]. 
Conversely, method 2 showed that the OCM were more sluggish than normal weight microbiota, 
producing far fewer SCFA during the first half of fermentation compared with NCM. When 
considering that obese individuals generally consume less dietary fiber than normal weight 
individuals, it may be that the obese microbiota are less active due to less substrate availability in 
vivo. Thus, more research on the metabolic and functional differences in the microbiota between 
obese and normal weight humans is necessary. 
Among individual SCFAs produced, no significant differences were found in the butyrate 
production with method 1, while with method 2 the NCM produced more butyrate than the OCM. 
The lack of a statistical difference in the former case may simply be due to an insufficient n. 
Notably, we only analyzed the SCFA production at the end of 12 h in method 1, while 
SCFA production at 6, 12, and 24 h were quantified in method 2. At 12 h of fermentation in both 
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methods, no significant differences were observed in total SCFA production between the normal 
weight and obese groups (176.56±16.53 μmol/100mg carbohydrate vs. 194.99±16.98 
μmol/100mg carbohydrate for method 1, respectively, p for difference=0.25). The differences 
discovered in method 2 were mostly a result of shorter (6 h) or longer (24 h) fermentation times 
(Figure 3.4 and Table 3.3). It may be that more consistent results would have been observed 
between methods 1 and 2 had fermentation samples been taken at multiple time points in method 
1.  
3.6. Conclusion 
Whole grains have been associated with reduced obesity risk, though the influence on the gut 
microbiota remains largely unknown. Large variations exist in fermentation properties among 
microbiota from different individuals, even when given the same substrate. Thus, no differences 
in SCFA production with increasing BMI were observed. When fecal samples were combined, 
however, to produce composite microbiota from each weight group, those from normal weight 
individuals were more metabolically active at the onset of fermentation compared to those from 
obese individuals, while the converse was true for the latter stages of fermentation. Also, more 
butyrate production was found from NCM at the end of fermentation. Although large variation 
exists in the SCFA profile among different individuals, our study showed that different whole 
grains influence the NCM and OCM in different fashions and may therefore elicit different 
physiological effects on our health.  
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Figure 3.1. Graphical depiction of fermentations using method 1 and method 2; a fecal samples from obese individuals (n=8); b fecal samples from 
normal weight individuals (n=7).
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Figure 3.2. Short chain fatty acid (SCFA) production from each fecal sample on each dietary fiber substrate arranged by body mass index (BMI) of 
the person the fecal sample was collected from control containing no whole grain substrate has been subtracted. 
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Figure 3.3.Gas production for corn, rye,oat, wheat, and rice; OCM (circles) and NCM (squares); values are presented as mean ± SE at each time 
point; * p<0.05 for difference from NCM at that time point. 
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Figure 3.4. Rate of short chain fatty acid (SCFA) production during different stages of fermentation; values are presented as mean production from 
each weight group with data from all whole grain substrates combined; error bars show standard error; * indicates a significant difference at that 
time interval (p<0.05).
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Table 3.1.Polysaccharide composition (%, db)a of whole grain samples before and after in vitro digestion.b 
Whole 
grain 
sample 
Starch%(db) Dietary Fiber 
Starch 
after in 
vitro 
digestion 
Carbohydrate content after in vitro 
digestion(Neutral sugar+uronic acid) 
    Neutral 
Sugars 
Uronic 
Acid Lignin Total 
  Neutral 
Sugars 
Uronic 
acid Total 
Wheat 59.53± 0.067 9.22±0.51 1.29±0.07 2.04±0.02 11.58±0.54 4.49±0 38.31±0.38 1.38±0.03 39.68±0.35 
Rice 75.41± 0.21 2.35±0.15 0.58±0.03 1.51±0.14 4.01±0.26 2.26±0.01 14.01±0.92 1.08±0.03 15.09±0.89 
Oats 59.46± 0.55 7.24±0.07 1.14±0.06 2.38±0 9.90±0.11 2.57±0.05 26.60±0.10 1.89±0.05 28.49±0.05 
Corn  63.27± 0.11 6.60±0.58 0.43±0.03 1.49±0.16 8.51±0.65 3.44±0.03 31.02±0.54 2.06±0 33.08±0.53 
Ryec 33.58± 0.45 23.67±1.09 0.51±0.06 4.74±0.14 28.92±1.09 2.85±0.02 46.36±0.11 1.18±0.02 47.54±1.09 
a  db: dry basis 
b  Each value represents mean ±standard error of 2 replicates 
c The rye used was not whole grain; it contained added bran
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Table 3.2. Individual SCFA and BCFAa production (method 1)b 
Whole 
grain Group 
Metabolite 
Gas Acetate Propionate Butyrate Iso-butyrate Iso-valerate 
Control Normal  1.13(0.13)
d 98.70(9.35)de 9.57(2.38)d 7.04(3.05)ab 1.93(1.28)ns 6.48(2.87)ab 
 
Obese 0.86(0.13)
d 80.61(11.64)e 7.92(1.94)d 5.39(2.20)b 1.24(1.17)ns 2.67(7.38)b 
Corn Normal  3.97(0.34)
c 215.95(21.41)bc 27.71(9.55)abcd 1.21(0.24)b 2.39(1.67)ns 7.25(3.30)ab 
 
Obese 4.03(0.49)
c 167.05(19.71)cd 28.24(10.13)abcd 2.15(0.61)b 0.56(0.24)ns 6.47(10.24)ab 
Rye Normal  4.73(0.37)
bc 218.91(20.40)bc 11.81(3.31)cd 16.60(5.23)a 2.25(1.47)ns 8.22(3.85)ab 
 
Obese 4.82(0.34)
bc 230.15(25.7)bc 16.53(4.58)cd 15.92(6.56)a 1.52(0.77)ns 9.29(9.34)ab 
Oats Normal  4.55(0.29)
bc 236.38(19.75)bc 26.41(8.90)bcd 1.37(0.36)b 1.93(1.57)ns 8.44(3.27)ab 
 
Obese 4.81(0.55)
bc 241.65(31.77)b 33.10(11.30)abc 9.96(5.11)ab 1.59(1.03)ns 11.63(10.61)ab 
Wheat Normal  4.68(0.42)
bc 245.38(18.20)b 16.31(3.38)cd 5.72(2.9)b 2.07(1.35)ns 7.20(2.73)ab 
 
Obese 4.84(0.48)
bc 222.58(24)bc 23.39(6.77)bcd 6.63(2.14)b 0.95(0.80)ns 9.77(11.88)ab 
Rice Normal  5.89(0.58)
ab 391.89(49.5)a 41.85(11.09)ab 1.87(0.34)b 2.21(1.86)ns 8.75(3.77)ab 
  Obese 6.42(0.89)
a 391.40(43.78)a 49.58(10.47)a 6.21(1.94)b 3.88(2.00)ns 15.62(20.55)a 
a SCFA: short chain fatty acid; BCFA: branched chain fatty acid. 
b Values are reported as mean (standard error) of 2 replicates from each individual in the normal weight (n=7) and obese (n=8) groups; units for 
gas are ml/tube (100 mg initial carbohydrate); for SCFA and BCFA, units are μmol/tube (100 mg initial carbohydrate); values carrying different 
superscript letters within column are significantly different (p<0.05). 
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Table 3.3.Composite SCFA a production (method 2) b 
    Metabolite 
Whole 
grain Group 
Acetate Propionate Butyrate 
6h 12h 24h 6h 12h 24h 6h 12h 24h 
Control Normal 43.71(0.22)c 104.18(2.07)g 230.1(3.16)d NDd C 6.05(2.22)def 36.26(0.15)c NDc NDd 20.93(0.29)bcd 
 Obese 8.12(0.05)
d 34.34(0.12)h 73.83(20.37)e 1.62(0.01)c 6.19(0.1)def 10.64(0.01)g 1.2(0.39)bc 2.56(0.18)bc 2.14(0.28)d 
Corn Normal 11.3.8(1.54)a 187.55(6.37)d 380.94(2.77)c NDd 21.28(0.46)b 47.88(1.85)b 3.37(3.37)b 1.50(0.14)bcd 12.19(0.13)cd 
 Obese 11.59(1.18)
d 122.22(3.56)ef 187.65(6.96)d 2.44(0.29)a 7.98(0.51)cde 45.60(0.6)b 1.54(0.14)bc 1.38(0.05)bcd 4.63(0.73)cd 
Rye Normal 98.04(1.72)b 210.41(0.58)c 464.63(0.11)bc NDd 7.23(0.51)cde 19.07(0.33)f NDc 1.37(0.04)bcd 22.66(0.96)bc 
 Obese 12.71(0.71)
d 108.63(0.06)fg 246.30(1.84)d 1.88(0.15)bc 8.75(0.17)cd 29.60(0.07)d 1.43(0.04)bc 1.31(0.23)bcd 1.58(0.10)d 
Oats Normal 110.60(2.35)a 219.09(9.66)bc 461.95(38.41)bc NDd 20.3(1.33)b 28.57(2.39)d 9.1(0.57)bc 2.93(0.21)ab 72.73(18.11)a 
 Obese 13.43(0.11)
d 132.05(3.21)e 258.15(53.13)d 2.03(0.01)b 7.45(0.05)cde 44.71(0.24)b 1.22(0.25)bc 1.17(0.14)cd 5.86(1.08)cd 
Wheat Normal 91.67(4.16)b 229.95(4.87)bc 402.61(24.61)c NDd 10.83(0.50)c 24.06(2.72)e NDc 4.32(1.72)a 35.39(3.07)b 
 Obese 10.8(0.25)
d 121.41(0.65)ef 197.38(7.95)d 1.87(0.04)bc 4.26(0.05)fe 36.89(0.66)c 1.55(0.1)bc 1.56(0.04)bcd 2.75(1.70)d 
Rice Normal 117.92(13.02)a 432.39(4.07)a 666.06(58.47)a NDd 31.41(3.47)a 39.33(0.56)c 2.4(0.28)bc 2.60(0.01)bc 55.387(9.533)a 
  Obese 13.50(0.62)d 214.42(11.19)bc 518.39(28.05)b 1.74(0.07)bc 2.70(0.13)f 64.26(0.25)a 1.79(0.15)bc 1.62(0.47)bcd 6.62(2.08)cd 
a SCFA: short chain fatty acid; 
b Values are reported as mean (standard error) of 2 replicates from each individual in the normal weight (n=7) and obese (n=8) groups; units for 
gas are ml/tube (100 mg initial carbohydrate); for SCFA and BCFA, units are μmol/tube (100 mg initial carbohydrate); values carrying different 
superscript letters within column are significantly different (p<0.05). 
c none detected.
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Table 3.4. BCFA a production (method 2) b 
    Metabolite 
Whole 
grain Group 
Iso-butyrate Iso-valerate 
6h 12h 24h 6h 12h 24h 
Control Normal 2.7(0.13)ab 2.90(0.22)a 9.70(0.5)ab 0.78(0.78)cd 5.92(0.92)bc 14.95(0.71)cd 
 Obese 0.14(0.14)
ab NDb 4.61(4.61)bc 1.63(0.07)bc NDf 5.70(4.12)defg 
Corn Normal 2.84(2.84)a NDb 10.78(0.58)ab NDd NDf 27.71(1.01)ab 
 Obese 1.14(0.17)
ab NDb 0.67(0.19)c 1.79(0.47)b 0.81(0.23)ef 2.81(0.16)fg 
Rye Normal 0.81(0.81)ab 2.75(0.01)a 6.21(0.3)bc NDd 8.32(0.28)b 13.37(0.42)cde 
 Obese 1.02(0.01)
ab 0.65(0.65)b 0.81(0.19)c 1.03(0.08)bc 1.68(0.12)def 1.44(0.09)g 
Oats Normal NDb NDb 6.19(0.58)c NDd 3.11(0.89)cde 18.28(1.26)bc 
 Obese 0.84(0.02)
ab NDb 0.86(0.06)c 1.97(0.22)b 1.15(0.08)def 2.48(0.20)g 
Wheat Normal NDb 1.04(0)b 8.21(1.12)ab NDd 3.62(0.94)cd 12.20(4.81)cdef 
 Obese 0.63(0)
b NDb 0.78(0.09)c 3.93(0.47)a 2.09(0.53)def 4.43(1.57)efg 
Rice Normal NDb 4.04(1.46)a 12.73(3.98)a NDd 11.78(2.53)a 33.28(7.42)a 
  Obese 0.46(0.06)ab NDb 6.62(2.08)abc 3.03(0.19)a NDf 16.18(1.39)c 
a BCFA: branched chain fatty acid. 
b Values are reported as mean (standard error) of 2 replicates from each individual in the normal weight (n=7) and obese (n=8) groups; units for 
gas are ml/tube (100 mg initial carbohydrate); for SCFA and BCFA, units are μmol/tube (100 mg initial carbohydrate); values carrying different 
superscript letters within column are significantly different (p<0.05). 
c none detected
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GENERAL CONCLUSIONS 
The present thesis has reported the impact of dietary fiber and whole grain on the fecal 
microbiota from obese and normal weight individuals. The first hypothesis was that whole grain 
and dietary fibers may be an excellent way to treat the obesity by altering and modulating of the 
gut microbiota. The second hypothesis was that different whole grains and dietary fibers will 
exhibit varying efficacy with respect to correcting the abnormal gut microbiota in obesity. 
 For the first hypothesis, we only evaluated the impact of dietary fibers (and not whole 
grains) on gut microbiota due to limitations on the number of samples we could run. Our results 
showed that RS-2 caused the most dynamic change of the whole microbiota community and 
dietary fiber can influence the growth of certain bacterial taxa. For instance, Bifidobacterium, 
which has been shown to be more abundant in normal weight individuals [1] increased almost 10-
fold on pectin. We also found that specific gut bacterial taxa were correlated with high SCFA 
production and/or utilization of certain dietary fibers.  These taxa may be targeted to increase 
SCFA production or increase DF utilization. Also, there were significant differences in the gut 
microbiota between obese and normal weight individuals; each of these microbiota respond 
slightly different to the same dietary fiber. 
 For the second hypotheses, it was demonstrated that different whole grains and dietary 
fibers exhibit quite different effects on the both the composition and the metabolic profile of the 
gut microbiota. Also, we found that there were large differences in fermentation profiles among 
individuals, even when supplied with the same dietary fiber or whole grain. The obese type 
microbiota was less efficient at butyrate production, and the obese type microbiota was less 
metabolically active than the normal weight type microbiota initially, but that given sufficient 
whole grain substrates the bacteria quickly became metabolically active. Epidemiological 
evidences suggest that obese individuals generally consume less whole grains than normal weight 
individuals [2-6]; our study suggests that whole grains may improve the metabolic function of the 
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aberrant microbiota in obese individuals and improve health by ramping up short chain fatty acid 
production.  
Although our study has shown that how different dietary fibers and whole grains can 
influence the gut microbiota community and metabolism, our knowledge in this area is still 
limited. More research at the genome level should be conducted to establish the relationships 
among dietary fiber and whole grain utilization, the growth of certain bacterial taxa, and 
metabolic diseases including obesity.  
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Appendix A. Selected SAS Code 
A.1.SCFA for Method 1 and Method 
SAS software (version 9.2, SAS Institute, Cary, NC) was used to determine statistical 
differences, which were defined as P<0.05, between gas, pH, short chain fatty acids (SCFA), and 
branched chain fatty acids (BCFA) during fermentation. Data were analyzed using a mixed model 
analysis of variance (PROC MIXED) with df (dietary fiber)  ,group as main effects. SCFA and 
BCFA were analyzed for each time point(6h,12h, and 24h) ANOVA was used.  
data example A1(butyrate); 
input df group ace but pro scfa ibu iva bcfa gas; 
datalines; 
[data] 
; 
proc glm; 
class df group; 
model but = df group df*group; 
means df group df*group; 
lsmeans df group df*group / pdiff lines; 
run; 
A.2.SAS was used to determine statistical differences, which were defined as P<0.05, of the shift 
of bacterial taxa (282) between different treatments (dietary fibers and control). ANOVA was 
used followed by with Tukey’s multiple comparison adjustment 
data classifier_TC; 
input sample $ trt $ X1-X282; 
cards; 
[data] 
; 
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proc print data = classifier_TC; 
run; 
proc glm data = classifier_TC; 
class trt; 
model X1-X282 = trt; 
lsmeans trt / pdiff lines adjust = tukey; 
run; 
A.3.Difference of Unifrac Index 
Repeated ANOVA (Graphpad grism 5.1) was used to determine the difference between 
different dietary fibers.  
A.4.difference of gut microbiota between fecal samples 
T-test was used to determine the statistical differences of the microbial compositions 
between obese and normal weight individuals. 
A.5. Difference of gut microbiota between obese and normal weight group after dietary fibers 
treatments 
T-test was used to determine the statistical differences of the microbial compositions 
between obese and normal weight individuals. 
A.6. Correlation between SCFA and bacterial taxa, CHO utilization and bacterial taxa 
Data example A6; 
Input A6 X1-X282; 
Datalines; 
[data] 
; 
Proc corr; 
var butyrate X1-X282; 
Run; 
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Appendix B. Detailed Methodology 
B.1. Total dietary fiber / carbohydrate assay [ 1] 
1. Weigh up to 300 mg of sample to contain about 10-20 mg total dietary fiber and not more 
than 180 mg starch into a 15 ml screw cap test tube. 
2. Add 3 ml of acetate buffer (0.1 M, pH 5, containing 5 mM CaCl2) and 25 µl of thermostable 
α-amylase (Sigma A-9505 or Megazyme); cap; mix; heat to boiling for 1 h. 
3. Cool; add 0.140 ml of amyloglucosidase (Sigma A-7095, 300 U/ml); incubate at 60 °C 
overnight. 
4. Cool; add 12 ml absolute ethanol; mix; leave for 1 h in an ice bath. 
5. Centrifuge at 800g for 10 min; discard supernatant; wash pellet by suspending and re-
centrifuging with 80% ethanol (2 × 20 ml) and then with acetone (2 × 15 ml). 
6. Insert glass rod in test tube and mix occasionally while pellet dries; allow pellet to dry 
completely overnight in the hood; 
7.  Add 0.3 ml of 12 M sulfuric acid; let stand at 30 °C for 1 h; turn water bath to 40 °C. 
8. Add 1 ml of myo-inositol (amount of inositol added should approximate the average of the 
individual sugar contents, about 3 mg/ml) and 7.4 ml of water; add water in such a way as to 
wash the glass rod of any remaining residue and remove glass rod; make sure there is no 
residue clinging to the side of the test tube.  
9. Pressure cook tubes on HIGH for 1 h. 
10. Filter hot hydrolysate through a dry, tared, frittered glass crucible into a 25 ml volumetric 
flask thoroughly rinse the tube and crucible with water; make sure to transfer all of the solids 
to the glass crucible; this is the hydrolysate syrup (H). 
11. Dry crucible in oven at 105 °C for 16 h (or overnight); re-weigh (Wi); ash in furnace at 500 °C 
for 1 h (place crucible in cold furnace, heat to 500 °C at 10 °C/min, hold at 500 °C for 1 h, 
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cool to 100 °C at 3 °C/min); remove from oven and cool completely in a dessicator before 
weighing (Wf). 
a. 𝐾𝐿 = �𝑊𝑖−𝑊𝑓�×100%
𝑆
 
b. All weights are in mg 
12. Add 0.357 ml of hydrolysate syrup (H) to a 35 ml tube; add 71 µl of 12 M ammonium 
hydroxide (8 ml of 30% ammonium hydroxide diluted to 10 ml); mix; add 36 µl of freshly 
prepared 3 M ammonium hydroxide (2 ml of 30% ammonium hydroxide diluted to 10 ml) 
containing 150 mg/ml sodium borohydride; add 5 µl 2-Octanol; incubate at 40 °C for 1.5 h. 
13. Add 36 µl of glacial acetic acid; mix; add 0.5 ml of 1-methylimidazole; mix; add 5 ml of 
acetic anhydride; mix; let stand 10 min at room temperature. 
14. Add 1 ml absolute ethanol; let stand 10 min at room temperature. 
15. Move tubes to a cooler with ice up to shoulder of tube. 
16. Slowly add 5 ml of well mixed 7.5 M sodium hydroxide; mix; add another 5 ml of 7.5 M 
sodium hydroxide. 
17. Transfer ethyl acetate (top) layer to a fresh tube; make sure not to transfer any aqueous phase 
to tube; if so, dry with anhydrous sodium sulfate and transfer to another tube. 
18. Separate alditol acetates using the following conditions: 
a. Injection volume: 1 µl 
b. Inlet temperature: 240 °C 
c. Carrier gas: He @ 2 ml/min 
d. Split ratio: 1:20 
e. Column: Elite 225,PerkinElmer N9316177, 30m×0.25mm×0.25µm 
f. Temperature program: Isocratic @ 220 °C for 25 min 
g. Detector temperature: 240 °C 
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19. Quantify alditol acetates relative to inositol peak using correction factors obtained from 
known standards (arabinose, xylose, mannose, glucose, galactose) 
a. 𝐶𝐹𝑀𝑆 = 𝐴𝑆𝑡𝑑×𝑊𝑀𝑆𝐴𝑀𝑆×𝑊𝑆𝑡𝑑 
b. 𝑀𝑅 = 𝐶𝐹𝑀𝑆×𝐴𝑀𝑆×𝑊𝑆𝑡𝑑×𝐹𝑚×100%
𝐴𝑆𝑡𝑑×𝑆  
c. 𝐹𝑚= 0.88 for pentoses; 0.9 for hexoses; S = sample weight in mg 
20. Add 125 µl of hydrolysate syrup (H) or 125 µl of galacturonic acid monohydrate (150 mg/ml; 
Std) to a 5 ml screw cap tube; add 125 µl of NaCl/boric acid (2 g NaCl and 3 g boric acid/100 
ml); add 2 ml of concentrated sulfuric acid; mix immediately; cap; incubate at 70 °C for 40 
min. 
21. Cool; add 100 µl of freshly prepared 3,5-dimethylphenol (100 mg/100 ml in glacial acetic 
acid); mix several times over 5 min. 
22. Read absorbance at 400 and 450 nm. 
23. Calculate uronic acid content 
a. 𝑈𝐴 = 𝐴𝐻×150
𝐴𝑆𝑡𝑑
 
b. 𝑈𝑅 = 𝑈𝐴×𝐹𝑢×𝐹𝑐×100%
𝑆
 
c. Fu = 0.83 (monohydrate to residue); Fc = 0.81 (adjustment for absorbance of free uronic acid 
vs polyuronic acid) 
24. TDF = UA + UR + KL 
Notes: Total carbohydrate content (except Inulin): start from step 1(weigh 50mg samples), then 
add 0.3 ml of 12 M sulfuric acid, continue with step 8. 
 
B.2. In vitro digestion 
The in vitro digestion was followed by [3] with some modifications. 
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1. Whole grain flours and resistant starch-2 (25 g) were boiled for 20 min with 300 ml distilled 
water in a 500 ml beaker inside of another larger beaker that was filled with boiling water.  
2. After cooling to room temperature, ~8 ml of 1M HCl were added to the sample to reduce the 
pH to 2.5. Ten ml of 10% (w/v) pepsin (P-700, Sigma, St. Louis, MO USA) dissolved in 0.05M 
HCl was added and the mixture placed on an orbital shaker (150 rpm) at 37 ℃ for 30 min to 
achieve the gastric phase.  
3. The small intestinal phase was initiated with the addition of 50 ml 0.1 M sodium maleate 
buffer (pH=6, containing 1 mM CaCl2) and ~20 ml of 1 M NaHCO3 to bring the pH to 6.9. Fifty 
ml of 12.5% (w/v) pancreatin (P-7545, Sigma) dissolved in sodium maleate buffer and 2 ml of 
amyloglucosidase (3260 U/ml; Magazyme) were then added and samples were incubated in 
shaking water bath at 37 °C for 6 h. 
4. Digested contents were then poured into dialysis tubing (molecular weight cut off 12,000-
14,000) and dialyzed for 3 d against distilled water with changing of the water every 12 h. The 
retentate was then frozen (-20 ℃) overnight and then freeze dried.  
B.3. In vitro fermentation 
1.  The method was according to (3). Firstly, prepare phosphate buffered saline solution, separate 
them in 5 bottles and autoclave them with then store them in the anaerobic cabinet. 
2. Make nutrient medium in a 1 L beaker, autoclave it and add cysteine hydrochloride, vitamin K, 
and hemin in the anaerobic cabinet. Then divide into 5 sterile containers. 
Checklist for autoclave: 
a. Five bottles with buffer (cap slightly). 
b. Five bottles with nothing. 
c. 1L bottle with medium inside. 
d. Three 500ml flasks with AL foil cover on them. 
e. Cheesecloth. 
122 
 
 
3. Weigh 40mg/100mg carbohydrate into each tube. Include 2 blanks for each fecal preparation 
(blanks do not contain any sample in tube). 
4. Move the tubes to the anaerobic cabinet, add 4 ml/10ml nutrient basal medium (w/v=1%) to 
the tube. Cap the tubes and store them at 4 ℃ for 12 h. 
5. Mix 5g fecal sample with 50ml buffer (w/v=10%) in the anaerobic cabinet using the 0.00 
balance. Mix for 1 min on the blender. Filter the solution through 4 layers of cheesecloth into a 
clean flask. 
6. Inoculate each tube with 0.4ml/1ml of the solution above into each tube. Vortex the tubes and 
cap them, then put them in the shaking water bath (37 ℃) in cereal lab for 12h. 
7. At the end of 6, 12 h, and 24h, plunge tubes into an ice bath to slow bacterial metabolism. 
Allow to cool for 5 min. Transfer exactly 1 ml of fermentation slurry into micro centrifuge tubes 
(5 tubes). Swirl tubes while taking samples to ensure an even draw of liquid and solid material 
into each microfuge tube.  Store them in well-marked freezer boxes in the -80 ℃ freezer. 
Notes: 
1. The buffer solution contains resazurin. This is an indicator of anaerobic conditions. The 
indicator is colored (blue or pink) when oxygen is present and colorless when oxygen is not 
present. Before mixing your medium with samples, there should be no color from the resazurin 
(color of reduced medium will probably be pale yellow). 
2. When preparing the buffer, the cysteine hydrochloride, vitamin K, and hemin should be added 
AFTER autoclaving. Therefore, you will have to add these in the anaerobic hood. For this reason, 
it might be best to keep the medium in 1 container until you add the last components and then 
divide into 5 sterile containers (autoclave 5 empty Erlenmeyer flasks with Al foil over opening). 
3. Do not autoclave blender container. This will probably melt it. Just wash the containers well, 
soak in 10% bleach, and rinse. 
4. Cut the tip off of blue pipette tips to take samples. This will prevent particulates from clogging 
up the pipette tip 
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5. Only adjust the pH of the phosphate buffered saline solution, NOT the medium. It might be a 
good idea to check the pH of the medium, though. It should be close to 6.8 (actually it was closed 
to 7.4 in our experiment). 
Phosphate buffer g/L Nutrient medium  
NaCl 8 peptone water 2 g/L 
KCl 0.2 yeast extract 2 g/L 
Na2HPO4 1.15 NaCl 0.1 g/L 
KH2PO4 0.2 K2HPO4 0.04 g/L 
  
MgSO4·7H2O 0.01 g/L 
  
CaCl2·2H2O 0.01 g/L 
  
NaHCO3 2 g/L 
  
hemin 0.005 g/L 
  
L-cysteine hydrochloride 0.5 g/L 
  
bile salts  0.5 g/L 
  
Tween 80 2 ml/L 
  
 vitamin K 10 μL/L 
  resazurin solution 4 mL of 0.025% (w/v)/L 
 
B.4.SCFA assay 
1. Dissolve 20mg 4-methy valeric with 8ml water and add 2ml metaphosphoric acid (25% 
w/v) into it. 
2. Dissolve 20mg 4-methy valeric acid, 20mg acetate acid, 20mg butyric acid, 20mg 
isobutyric acid, 20mg propionic acid, 20mg valeric acid and 20 mg iso-valeric acid with 
8ml water , add 2ml metaphosphoric acid(25% w/v) into it . 
3. Add 0.2 ml solution in step 1 to 1 ml sample. 
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4. Add 0.2ml solution in step 2 to 1 ml water. 
5. Centrifuge at 16000rmp for 10min. 
6. Transfer the supernatant to a clean tube. 
7. Measure with GC. 
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Appendix C. Project Proposal. 
 
Ability of Specific Dietary Fibers to Normalize 
The Gut Microbiota in Obese states 
Summary: 
Current studies show that obese individuals harbor an abnormal gut microbiota (dysbiosis) 
that supports an increased capacity for harvesting energy from food. Considering that different 
dietary fibers and whole grain cereals have distinct chemical compositions and influence on the 
gut microbiota, a specific whole grain cereal or dietary fiber may most effectively alter the 
microbiota from the obese state and thus serve as an innovative strategy to treat obesity. We will 
subject several different kinds of whole grain cereals and dietary fibers to in vitro digestion and 
fermentation so as to imitate what happen in human gastric intestinal tract. Short chain fatty acid 
(SCFA) and gas production will be quantified and the shift of bacteria will be assessed by 
pryosequencing. We want to know which of the dietary fibers is most effective at shifting the gut 
microbiota to a healthier state. The outcomes can serve as preliminary results to the clinical trial 
testing the effect of certain dietary fibers on obesity.
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Justification and Objectives:   
  About one-third of U.S. adults (33.8%) are obese (Flegal et al 2010). Obesity is the key 
contributor to many metabolic syndromes worldwide such as hypertension, dyslipidemia, type 2 
diabetes, colon cancer, cardiovascular disease and stroke (Alison et al 2001). 
         Human intestines harbor an immensely complex and diverse microbiota that can be 
viewed as a super metabolic organ (15 fold-more genome than our host genome) with about 1014 
bacteria and Achaea, composed of approximately 1,100 prevalent species (Junjie Qin et al 2010). 
The gut microbota has been found to affect energy harvest from the diet and fat storage. Germ-
free (GF) mice are protected from diet induced obesity, and upon gut microbiota colonization a 
significant increase (42%) of body fat content occurs (Fredrik et al 2004). 
Gut microbiota composition has been associated with obesity. Decreased diversity of 
microbiota will certainly lead to a dysfunction of the whole gut ecosystem which will affect the 
stability of certain bacterial groups. Studies (Ley et al 2006, Zhang et al 2009 and Turnbaugh et al 
2009) show that there is a shift between two bacterial phyla (Bacteroidetes and Firmicutes in 
obese state): a reduction of Bacteroidetes and a proportional increase of Firmicutes in the process 
of weight gain. Also compared with lean people, there are relatively less Bacteroidetes in obese 
people, which are increased with weight loss. 
        The gut microbiota can be influenced by diet, particularly by dietary fibers in the diet. 
Indeed, certain dietary fibers can favor the growth of one or a group of bacteria at the expense of 
others (Gibson et al 1995). Moreover, obese people consistently consume less dietary fiber than 
normal-weight individuals (Davis et al 2006). Therefore, we hypothesize that whole grain and 
dietary fibers may be an excellent way to treat the obesity by altering and modulating of the gut 
microbiota. 
However, since whole grains and dietary fibers are actually composed of many chemical 
compounds with different physiological effects, we further hypothesize that different whole 
grains and dietary fibers will exhibit varying efficacy with respect to correcting the abnormal gut 
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microbiota in obesity. To test the hypothesis, we will use in vitro fecal fermentation to determine 
what kinds of whole grain and dietary fibers that can be most effective and efficient in altering 
the gut microbiota composition to a healthier state which may result in weight loss 
(Firmicutes:Bacteroidetes ratio and shift the obese microbiota toward that of normal weight 
individuals). The objectives of this study can deep our understanding of the relationship between 
diet, gut microbiota and obesity, which sever as the new way of weight loss. 
Literature review: 
Over 60% Americans are overweight and the prevalence of obesity increased 
dramatically in 1990s and a similar increase was seen in US children (Mokdad et al 1999). 
Despite the increased awareness of weight control, the population of obese people continues to 
increase according to the National Center of Disease Control & Prevention (Khan and Mokdad et 
al 2001). The change of diet may be novel approaches to treating obesity with high patient 
compliance due to minimal changes in physical habits. 
Dietary Fiber and Obesity: 
  AACC International gives the definition of dietary fibers as “the edible parts of plants or 
analogous carbohydrates that are resistant to digestion and absorption in the human small 
intestine with complete or partial fermentation in the large intestine.” It includes polysaccharides, 
oligosaccharides, lignin and associated plant substances (AACC). A common classification 
divides dietary fibers into two categories: insoluble dietary fibers consisting of cellulose, 
hemicellulose and lignin, and soluble dietary fibers containing pectin, gums, inulin, and some 
storage polysaccharides. Dietary fiber exhibits one or more beneficial effects either on laxation, 
blood cholesterol attenuation and blood glucose attenuation. Dietary fibers have been shown 
related to weight loss in many studies and the following part will discuss these studies and the 
mechanism of dietary fiber impacting on weight loss in detail. 
Much research has been devoted toward assessing the relationships between dietary fiber 
consumption and obesity including both epidemical studies using food frequency questionnaires 
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(FFQ) and intervention studies based on randomized controlled trials (RCT). Cross-sectional 
studies show a significant inverse association between dietary fiber consumption and Body Mass 
Index (BMI) (Vijai et al and Trucker). In 203 healthy men, it was reported that intakes of 
complex carbohydrate and dietary fiber were associated with reduced body fat, especially in 
highest body fat groups (Lisa et al 1996). In another study, increasing dietary fiber consumption 
significantly reduced the risk of weight gain and fat in women (Trucker et al 2009).   
        In spite of the convincing role of dietary fiber in preventing obesity suggested by 
epidemiological studies, clinical trials on weight loss and dietary fibers intake are also 
inconsistent. For instance, a double-blind controlled trial designed with 32 women showed a 
significantly higher decrease in body weight in subjects taking guar gum compared with the 
placebo group (Tuomilehto et al 1980), while a meta-analysis of randomized placebo controlled 
trials suggests that guar gum is not efficacious for reducing body weight (Pittler et al 2001). More 
RCT with a larger subject population and long term treatments may help to draw a more firm 
association between dietary fiber intake and weight loss. 
         There is still much debate about the exact mechanism of the function for dietary fiber on 
obesity. There are three proposed mechanisms for prevention of obesity with dietary fiber: 
physiological properties, hormone modulation of dietary fiber and impact on gut microbiota. 
1. Physiological Properties of Dietary fiber on obesity 
          The mechanism for prevention of obesity with dietary fiber can be stated as below: (1) 
On average, only 40% of dietary fiber are fermented in the colon and the capability of water 
binding properties for dietary fiber will lead to lower energy density compared with other refined 
carbohydrate matrix (Geraci et al 1993); The weight of food consumption for human is consistent 
(Roll et al) so high fiber food can displace energy and calories compared with high energy density 
food. (2) Increased dietary fiber consumption may have links to lower digestibility of fat and 
protein especially with high fat diet. Dietary fiber decreases the metabolizable energy content and 
nutrient digestibility of mixed diets fed to humans (Baer et al 1997). However, the SCFA 
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produced by the digestion of dietary fiber salvages some energy that may offset the effect stated 
above. Despite the offset, consumption of dietary fiber still brings about a small additional loss of 
energy intake. (3) Food containing dietary fiber tends to have a longer chewing time which will 
lead to more saliva excretion. As a consequence, it will take a longer time to eat the food and 
increase the feeling of satiety. (Aleixandre et al 2008);  
2. Hormone Modulation of Dietary Fiber. 
To increase satiety and reduce huger, it is important to note that the satiety effect of 
dietary fiber may be administered by several gut hormones including insulin, leptin, ghrelin, 
cholecystokinin (CCK) and glucagon-like peptide 1 (GLP-1), which can regulate the energy 
balance. Ghrelin is an endogenous peripheral hormone that can induce hunger and increase food 
intake (1)Ghrelin plays an important role in decreasing gastric acid secretion and stimulating 
gastric emptying (Masuda et al 2000). The consumption of ghrelin in rats increases food intake 
and decreases lipid oxidation (Kojima et al 2002). Dietary fiber can impact on ghrelin level in 
two ways. On one hand, it has been shown that fiber consumption can reduce the plasma ghrelin 
level in a randomized, single-blind, controlled, crossover intervention trial (Djurhuus et al 2002). 
Another pathway that has been reported is that dietary fiber intake can increase GLP-1 level that 
can suppress ghrelin secretion. 
Fermentable dietary fiber is shown to increased peptide-YY (PYY) levels in rodents 
(Greenway et al 2007).PYY is a gut hormone excreted by C-Cells and exerts impact mostly on 
lower gut intestine. PYY can reduce appetite in both obese and lean individuals (Batterham et al 
2003). Fermentable dietary fiber is shown to increased PYY levels in rodents (Greenway et al 
2007). However, other studies demonstrate that no significant differences have been found 
between lean and obesity individuals, suggesting that reduction of PYY level may be unrelated to 
obesity (Batterham et al 2003). Thus, it is still speculative whether there is relation between 
obesity and PYY. 
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        GLP-1 is secreted by L-Cells distributed along the intestinal tract (Murphy et al 2006). It 
has been shown that peripheral administration of GLP-1 inhibits food intake and appetite both in 
human and rats through their peripheral effect (vagal nerve) and by acting directly on the arcuate 
nucleus (Druce et al 2004). It has been found that consumption of dietary fiber leads to prolonged 
increase of plasma GLP-1(Gee et al 1996). In addition, DPPIV is an enzyme dipeptidylpeptidase 
IV (DPPIV) that has been involved in suppressing the activities and cleaving the GLP-1 (Burcelin 
et al 2001). Fiber intake may also reduce the DPPIV activities by about 30%. Some studies show 
GLP-1 is low in obese people and weight loss will lead to normalize this level (Verdich et al). 
Other studies have not seen this shift (Visbll et al 2001). It is still not conclusive whether the GLP 
will affect obesity. More research is needed to access the relationship between dietary fiber and 
hormone modulation. 
 3. Gut Microbiota, Dietary Fiber and Obesity 
 The bacteria in our gut belong to 4 phyla including gram positive, Actinobacteria, 
Firmicutes, and gram-negative Bacteroidetes and Proteobacteria. The microbiota in our gut has 
been coevolving with us and shows many manifested physiological and pathological impact on 
the host. It allows us to extract extra energy dietary fiber because the gut microbiota can express 
enzymes (lycoside hydrolases and polysaccharide lysas) that we do not express (Sonnenburg et al 
2005). Beyond that, the microbioa can also interact with the host in a symbiotic way that shapes 
and models our immune system and controls the regeneration of the intestinal epithelium (Lee et 
al 2010). 
The gut microbota has been shown to impact energy harvest from diet and fat storage 
(Bäckhed et al 2004). Moreover, by transplanting caecal sample from lean mice and obese mice  
to GF mice for two weeks, it is observed that mice with the microbiota from obese ones gain 
more fat and extract more calorie when compared with the others (Peter et a 2006). Different 
extraction of calorie from ingested food may be attributed to different composition of bacteria. 
For instance, the microbiota in obese people prone to extract more energy. The metabolism of 
131 
 
 
bacteria will enhance energy extraction (Dibaise et al 2008). Thus, microbiota composition has a 
profound impact on weight regulation. 
         The underlying mechanism for the role of the gut microbiota in obesity may be explained 
using GF mice: (1) Fasting-induced adipocyte factor (Fiaf) which acts as an inhibitor for 
lipoprotein lipase (LPL) can be selectively suppressed by the gut bacteria. LPL can enhance the 
storage of fat storage process in liver ( Bäckhed et al 2009). Fiaf is known as the angiopoietion-
like protein selected in liver and intestines. This protein can act as an inhibitor to LPL which is a 
key regulator for fatty acid release and adipocyte triglyceride accumulation. Interestingly, by 
comparing GF wild-type and Fiaf/knockout mice when fed with a western diet using same 
protocol, Fiaf- deficient animals appear to gain more weight than the corresponding wild-type 
mice. (2) Changing the level of AMP-activated protein kinase (AMPK).The AMPK plays a key 
role in regulating cellular energy metabolism. Increasing the AMPK lever will promote the fat 
oxidation process. Research from mouse study found a significantly high level of AMPK in the 
liver of GF mouse compared to the conventional mouse. It is also noted that maybe a higher level 
of NADH in the livers of germ free mice will activate the AMPK (Rafaeloff-Phail et al 2004).In 
addition; AMPK can be regulated by ADP. A fall in intracellular ATP levels can activate the 
energy producing pathway (Xiao et al 2011).        
Studies show that there is a shift between the two divisions (Bacteroidetes and 
Firmicutes): a reduction of Bacteroidetes and a proportional increase of Firmicutes with the 
process of weight gain (Ley et al 2006 and Turnbaugh et al 2006).It is also strikingly noted that 
compared with lean people, there is relatively less Bacteroidetes in obese people and 
accompanied with the weight loss, there will a substantial increase of Bacteroidetes with low 
calorie food. Although some other studies have not found significant difference between 
Firmicutes and Bacteroidetes (or the opposite), it is notable they have also found that obese 
individuals have distinctly different intestinal communities than normal-weight individuals 
(Zhang et al 2008). 
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        The short term change in some bacterial groups may be of great importance. From an 
ecological perspective, the alteration of certain bacteria by themselves in the long term will cause 
the change of relative population of many other groups through competing with the ecological 
niche which will impact on the metabolism status. 
       Using both dietary and physical intervention, there are significant microbiota changes 
between high weight loss group and the low weight loss group. For the total bacteria, B. fragilis 
group and Clostridium leptum group, and Bifidobacterium catenulatum group counts were 
significantly higher (P < 0.001–0.036) while levels of C. coccoides group, Lactobacillus group, 
Bifidobacterium, Bifidobacterium breve, and Bifidobacterium bifidum were significantly lower (P 
< 0.001–0.008) in the high weight–loss group than in the low weight–loss group due to the 
intervention (Santa Cruz et al 2009). 
        To summarize, although many studies have been conducted to prove the relationship 
between whole grain food and dietary fiber intake with obesity, the results are controversial and 
the underlying mechanism remains unclear. Recently, metabolic disorder has been linked to the 
gastrointestinal microbiota. The connection between gut microbiota and weight gain may give an 
innovative strategy for the prevention and treatment of obesity. Dietary intervention (whole grain 
and fibers) has been shown to reshape and modulate the gut microbiota and the specific kind of 
dietary intervention is of great value and significance which can modulate gut microbiota most 
effectively to promote a lean state. 
Experimental Design and Procedures: 
      Seven obese and six normal weight people based on the BMI will be identified from the 
patient database at Rush University Medical Center. Stool samples were collected from both 
obese and normal weight people without any known gastrointestinal disease or antibiotic 
consumption in the past 6 months. Fecal samples were collected through a specimen hat inserted 
under the toilet seat and mailed to UNL in Anaerocult C bags with oxygen absorbers on dry ice. 
The fecal samples were stored under -80 degree before analysis. 
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1. In vitro digestion 
       In vitro digestion was performed using a variety of cereal grains (corn, wheat, rye, rice 
and oats) and purified dietary fiber (resistant starch type-2, beta-glucan, inulin, corn arabinoxylan 
(AX), pectin and guar gum). Beta-glucan and AX were purified in the lab. Beta-glucan was 
extracted as in Irakli et al. (J. Sci. Food Agric. 2004, 84, 1170-1178), except beta-glucan was 
precipitate with ethanol rather than ammonium sulfate. AX was extracted by treating corn bran 
with Termamyl, Neutrase, and AMG followed by 1 M NaOH. The extracted AX was bleached 
with hydrogen peroxide and precipitated with ethanol and dried with acetone. The in vitro 
digestion was followed by Mishra et al (J of Cereal Science 50(2009) 61-66) with some 
modifications: the cereal grain samples (25g) were treated with 50 ml 12.5% α-amylase and 2ml 
AMG and the digestion process was increased to 6 h. The reason why we made this modification 
is that in the preliminary study with the enzyme concentration stated in the paper, starch cannot 
be effectively removed and the remaining starch in the sample is high which may affect the 
dietary fiber fermentation. This process mimics food digestion in human gastrointestinal tract 
which contains a gastric phase and small intestinal phase. In vitro digestion was followed by a 
dialysis process in which the monosaccharide produced during the digestion and protein 
hydrolysates were removed. Freeze drying of the dialysate was the last step to obtain the samples 
ready for in vitro fermentation. The dried samples were stored under -20 degree before analysis. 
Total starch assay of whole grain sample after in vitro digestion (AACC DMSO method) 
was performed to check whether starch was digested during the in vitro digestion process. Total 
carbohydrate assay is used for both whole grain sample and purified dietary fiber sample. Total 
carbohydrate content was assessed based on the neural sugar and uronic acid according to the 
AACC 32-25 method .For inulin sample, since the fructan will degrade during acid hydrolyze 
step. The carbohydrate content will be measured with AACC method 32-32 and AOAC Method 
999.03. 
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2. In vitro fermentation 
  Small scale 12 h in vitro fermentation was completed using different weight (but with the 
same total carbohydrate content) of cereal grain and dietary fiber samples after in vitro digestion. 
This process is followed in Sanz et al (J.Agri.Food Chem.2005, 53, 5192-5199) with a larger 
sample size. Gas production and short chain fatty acid data is measured and analyzed with SAS 
software. SAS was used to see the relationship between BMI, SCFA production and gas 
production. SCFA were quantified based on the protocol described by Campbell and coworkers (J 
Nutr 1997, 127:130–136) with small modification .Briefly, 1ml culture sample were removed 
from storage at -80°C and thawed on ice. The samples were added with 0.25ml 5 %( w/v) 
metaphosphoric acid containing 5-10 mM 4-methylvaleric acid and vortexed, followed by 
centrifugation for 10 min at 16,000 rpm. The supernatant was stored overnight at -20°C. Next, 
samples were thawed and centrifuged in the same conditions as before. SCFA were quantified by 
gas chromatography. 
 
3. Microbial composition 
      Microbial composition was assessed before in vitro fermentation and after in vitro 
fermentation by deep pyrosequencing of 16S ribosomal RNA genes amplified by PCR from the 
community in the Core for Applied Genomics and Ecology (CAGE). 
 
4. Total carbohydrate measurement 
      Total carbohydrate content remaining in the culture slurry after in vitro fomentation will 
be quantified to determine the consumption of each dietary fiber during the fermentation process. 
Since different dietary fibers have quite distinctive chemical compositions and physiological 
effects, specific bacteria may have unique mechanism of consuming certain types of dietary fibers 
more efficiently. The data will also be used to form hypotheses describing the relationship 
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between dietary fiber structure and the gut microbiota and obesity, which will be the basis for 
future research. 
Expected Outcomes: 
      The most important and primary outcome will be the shift between Firmicute and 
Bacteroidetes  after 12 h of  in vitro fermentation compared with the bacterial composition before 
in vitro fermentation using certain dietary fibers in obese groups. The difference of bacterial 
composition between obese and normal weight individual will be as another outcome. SCFA data 
will be used to assess the different fermentation profile of different groups. Thus, specific dietary 
fibers can be found which are mostly effective in shifting the obese type bacterium to a normal 
type one. 
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